<SEC-DOCUMENT>0000950170-24-088247.txt : 20240731
<SEC-HEADER>0000950170-24-088247.hdr.sgml : 20240731
<ACCEPTANCE-DATETIME>20240731080009
ACCESSION NUMBER:		0000950170-24-088247
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20240726
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20240731
DATE AS OF CHANGE:		20240731

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			SAB Biotherapeutics, Inc.
		CENTRAL INDEX KEY:			0001833214
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				853899721
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39871
		FILM NUMBER:		241159931

	BUSINESS ADDRESS:	
		STREET 1:		777 W 41ST ST
		STREET 2:		SUITE 401
		CITY:			MIAMI BEACH
		STATE:			FL
		ZIP:			33140
		BUSINESS PHONE:		305-845-2813

	MAIL ADDRESS:	
		STREET 1:		777 W 41ST ST
		STREET 2:		SUITE 401
		CITY:			MIAMI BEACH
		STATE:			FL
		ZIP:			33140

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Big Cypress Acquisition Corp.
		DATE OF NAME CHANGE:	20201120
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>sabs-20240726.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!-- DFIN New ActiveDisclosure (SM) Inline XBRL Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2024-07-30T16:49:44.5852+00:00 -->
<!-- Copyright (c) 2024 Donnelly Financial Solutions, Inc. All Rights Reserved. -->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:nonNumeric="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:sabs="http://www.sab.bio/20240726" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2022-02-16">
 <head>
  <title>8-K</title>
  <meta http-equiv="Content-Type" content="text/html"/>
 </head>
 <body style="margin: auto!important;padding: 8px;">
  <div style="display:none;"><ix:header><ix:hidden><ix:nonNumeric id="F_a8e37b87-cda3-4847-9e63-87ec0c5307e9" name="dei:EntityCentralIndexKey" contextRef="C_e0fd659c-47e7-4b88-95e5-f49ed5ee90dc">0001833214</ix:nonNumeric><ix:nonNumeric id="F_15654233-edf6-4004-aa4f-194c3064fe52" name="dei:AmendmentFlag" contextRef="C_e0fd659c-47e7-4b88-95e5-f49ed5ee90dc">false</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:type="simple" xlink:href="sabs-20240726.xsd"/></ix:references><ix:resources><xbrli:context id="C_e0fd659c-47e7-4b88-95e5-f49ed5ee90dc"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833214</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-26</xbrli:startDate><xbrli:endDate>2024-07-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_2b02be66-d2d4-400e-be24-3cd033b7a868"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833214</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">sabs:WarrantsEachExercisableForOneShareOfCommonStockAtExercisePriceOf11.50PerShareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-26</xbrli:startDate><xbrli:endDate>2024-07-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_61e14643-1b49-499f-ba28-dec792a3efce"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001833214</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:ConvertibleCommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-26</xbrli:startDate><xbrli:endDate>2024-07-26</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div>
  <div style="min-height:0.5in;"></div>
  <p style="border-top:2.25pt double #000000;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:5.75pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:18pt;font-family:Times New Roman;min-width:fit-content;">UNITED STATES<br/>SECURITIES AND EXCHANGE COMMISSION<br/></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">WASHINGTON, D.C. 20549</span></p>
  <p style="margin-left:40%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid #000000;margin-right:40%;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:18pt;font-family:Times New Roman;min-width:fit-content;">FORM </span><span style="font-size:18pt;font-family:Times New Roman;"><ix:nonNumeric id="F_6e255dc3-d617-46ef-96c3-f3c2b68412ea" contextRef="C_e0fd659c-47e7-4b88-95e5-f49ed5ee90dc" name="dei:DocumentType"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:18pt;font-family:Times New Roman;min-width:fit-content;">8-K</span></ix:nonNumeric></span></p>
  <p style="margin-left:40%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid #000000;margin-right:40%;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">CURRENT REPORT</span></p>
  <p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:6pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:100%;"/>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.02986111111111111in;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Date of Report (Date of earliest event reported): </span><span><ix:nonNumeric id="F_0282d1ff-295a-413b-8952-cdc853ea3e10" contextRef="C_e0fd659c-47e7-4b88-95e5-f49ed5ee90dc" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">July 26, 2024</span></ix:nonNumeric></span></p></td>
   </tr>
  </table>
  <p style="margin-left:40%;font-size:10pt;margin-top:5pt;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid #000000;margin-right:40%;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:5pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:24pt;font-family:Times New Roman;"><ix:nonNumeric id="F_553f0258-1e5c-4682-ab4f-1f248325a070" contextRef="C_e0fd659c-47e7-4b88-95e5-f49ed5ee90dc" name="dei:EntityRegistrantName"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:24pt;font-family:Times New Roman;min-width:fit-content;">SAB BIOTHERAPEUTICS, INC.</span></ix:nonNumeric></span></p>
  <p style="font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">(Exact name of Registrant as Specified in Its Charter)</span></p>
  <p style="margin-left:40%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid #000000;margin-right:40%;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:20%;"/>
    <td style="width:1%;"/>
    <td style="width:20%;"/>
    <td style="width:18%;"/>
    <td style="width:41%;"/>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td colspan="3" style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_d99ed54a-5b87-44d6-8465-c7a00efc2094" contextRef="C_e0fd659c-47e7-4b88-95e5-f49ed5ee90dc" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Delaware</span></ix:nonNumeric></span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_2ab1a74a-8dcb-4271-9bdc-79f047691453" contextRef="C_e0fd659c-47e7-4b88-95e5-f49ed5ee90dc" name="dei:EntityFileNumber"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">001-39871</span></ix:nonNumeric></span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_7e50d2ee-5e05-4da1-92fe-dc112e66a79d" contextRef="C_e0fd659c-47e7-4b88-95e5-f49ed5ee90dc" name="dei:EntityTaxIdentificationNumber"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">85-3899721</span></ix:nonNumeric></span></p></td>
   </tr>
   <tr style="height:7pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td colspan="3" style="padding-top:0.01in;vertical-align:top;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">(State or Other Jurisdiction<br/>of Incorporation)</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">(Commission File Number)</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">(IRS Employer<br/>Identification No.)</span></p></td>
   </tr>
   <tr style="word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td colspan="3" style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_1af538b4-751e-4925-b704-56ca8bfe0b75" contextRef="C_e0fd659c-47e7-4b88-95e5-f49ed5ee90dc" name="dei:EntityAddressAddressLine1"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">777 W 41st St</span></ix:nonNumeric></span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_066617d4-45fd-40f6-80fb-9185226ae819" contextRef="C_e0fd659c-47e7-4b88-95e5-f49ed5ee90dc" name="dei:EntityAddressAddressLine2"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Suite 401</span></ix:nonNumeric></span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td colspan="3" style="padding-top:0.01in;vertical-align:top;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_4f4f692a-44ce-4b76-a4a2-1d920f97b097" contextRef="C_e0fd659c-47e7-4b88-95e5-f49ed5ee90dc" name="dei:EntityAddressCityOrTown"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Miami Beach</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">, </span><span><ix:nonNumeric id="F_770f53d1-2ee7-4495-a005-ea5b9a4e8f19" contextRef="C_e0fd659c-47e7-4b88-95e5-f49ed5ee90dc" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Florida</span></ix:nonNumeric></span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_20f09587-3166-4a38-9fbd-6915c5dc7d33" contextRef="C_e0fd659c-47e7-4b88-95e5-f49ed5ee90dc" name="dei:EntityAddressPostalZipCode"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">33140</span></ix:nonNumeric></span></p></td>
   </tr>
   <tr style="height:7pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td colspan="3" style="padding-top:0.01in;vertical-align:top;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">(Address of Principal Executive Offices)</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">(Zip Code)</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:100%;"/>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td style="padding-top:0.125in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.02986111111111111in;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Registrant&#8217;s Telephone Number, Including Area Code:</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span><span><ix:nonNumeric id="F_62b8ea17-f31a-4ca7-adb6-3eafafce6967" contextRef="C_e0fd659c-47e7-4b88-95e5-f49ed5ee90dc" name="dei:CityAreaCode"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">305</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span><span><ix:nonNumeric id="F_4c820b10-6f96-4e0a-9ff0-c8d8de281205" contextRef="C_e0fd659c-47e7-4b88-95e5-f49ed5ee90dc" name="dei:LocalPhoneNumber"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">845-2813</span></ix:nonNumeric></span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:100%;"/>
   </tr>
   <tr style="word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td style="padding-top:0.125in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">(Former Name or Former Address, if Changed Since Last Report)</span></p>
  <p style="margin-left:40%;font-size:10pt;margin-top:9.35pt;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid #000000;margin-right:40%;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:9.35pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <div style="text-indent:-24.5pt;padding-left:24.5pt;margin-top:9pt;margin-bottom:0;text-align:left;"><span style="margin-right:1em;margin-right:1em;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_2e72727e-559f-4e26-ad00-a781ecc59436" contextRef="C_e0fd659c-47e7-4b88-95e5-f49ed5ee90dc" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox"><span style="font-size:10pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></div>
  <div style="text-indent:-24.5pt;padding-left:24.5pt;margin-top:6pt;margin-bottom:0;text-align:left;"><span style="margin-right:1em;margin-right:1em;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_92034988-e9d3-491f-ac87-99ddadb10753" contextRef="C_e0fd659c-47e7-4b88-95e5-f49ed5ee90dc" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox"><span style="font-size:10pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></div>
  <div style="text-indent:-24.5pt;padding-left:24.5pt;margin-top:6pt;margin-bottom:0;text-align:left;"><span style="margin-right:1em;margin-right:1em;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_c109cb40-322a-452b-a087-70c7a61d05e6" contextRef="C_e0fd659c-47e7-4b88-95e5-f49ed5ee90dc" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox"><span style="font-size:10pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></div>
  <div style="text-indent:-24.5pt;padding-left:24.5pt;margin-top:6pt;margin-bottom:0;text-align:left;"><span style="margin-right:1em;margin-right:1em;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_67ad8dad-1b6b-44c5-826e-5f8c99ed602f" contextRef="C_e0fd659c-47e7-4b88-95e5-f49ed5ee90dc" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox"><span style="font-size:10pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></div>
  <p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:9pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Securities registered pursuant to Section 12(b) of the Act:</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:38%;"/>
    <td style="width:1%;"/>
    <td style="width:15%;"/>
    <td style="width:1%;"/>
    <td style="width:45%;"/>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:top;border-bottom:0.25pt solid;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"><br/>Title of each class</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;border-bottom:0.25pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;border-bottom:0.25pt solid;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Trading<br/>Symbol(s)</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;border-bottom:0.25pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;border-bottom:0.25pt solid;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"><br/>Name of each exchange on which registered</span></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:top;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_22b38018-1eab-4680-ad2e-14374452489b" contextRef="C_61e14643-1b49-499f-ba28-dec792a3efce" name="dei:Security12bTitle"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Common stock, $0.0001 par value per share</span></ix:nonNumeric></span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_0b9f509e-91d7-4841-a7e1-d97f1d8018ac" contextRef="C_61e14643-1b49-499f-ba28-dec792a3efce" name="dei:TradingSymbol"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">SABS</span></ix:nonNumeric></span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_088e8f9f-2da8-489d-a21d-1d9187dfac54" contextRef="C_61e14643-1b49-499f-ba28-dec792a3efce" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">The Nasdaq Stock Market LLC</span></ix:nonNumeric></span></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:top;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_90dd2a46-62c1-45fb-a881-b8a3fc4c73fc" contextRef="C_2b02be66-d2d4-400e-be24-3cd033b7a868" name="dei:Security12bTitle"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Warrants, each exercisable for one share of Common Stock</span></ix:nonNumeric></span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_e4c46832-a013-44c5-b70e-a53b496d4ed8" contextRef="C_2b02be66-d2d4-400e-be24-3cd033b7a868" name="dei:TradingSymbol"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">SABSW</span></ix:nonNumeric></span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_0d4e90e7-030a-4f23-945b-b98c5193a8b3" contextRef="C_2b02be66-d2d4-400e-be24-3cd033b7a868" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">The Nasdaq Stock Market LLC</span></ix:nonNumeric></span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;&#8239;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;&#8239;240.12b-2 of this chapter).</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Emerging growth company </span><span style="font-size:10pt;"><ix:nonNumeric id="F_16513a7c-8d23-4c64-b2ee-6dddb50a859c" contextRef="C_e0fd659c-47e7-4b88-95e5-f49ed5ee90dc" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox"><span style="font-size:10pt;font-family:Times New Roman;">&#9746;</span></ix:nonNumeric></span></p>
  <p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="font-size:10pt;"><ix:nonNumeric id="F_95627ca7-d3e4-414c-b836-6e9c18ce8001" contextRef="C_e0fd659c-47e7-4b88-95e5-f49ed5ee90dc" name="dei:EntityExTransitionPeriod" format="ixt-sec:boolballotbox"><span style="font-size:10pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:2.25pt double #000000;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <div class="page-node-content"><div style="flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;"></div></div>
  <hr style="page-break-after:always;"/>
  <div style="min-height:0.5in;"></div>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Item 5.02 Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers.</span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On July 26, 2024, Lucy To, 38, was appointed Chief Financial Officer of SAB Biotherapeutics, Inc., a Delaware corporation (&#8220;SAB BIO&#8221; or the &#8220;Company&#8221;), with a start date of August 12, 2024.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Ms. To brings over 18 years of investment banking and strategic operational expertise to SAB BIO and will lead corporate finance, corporate strategy and approach to broader strategic business relationships at the Company. Prior to joining SAB BIO, she was a Managing Director in the Healthcare Investment Banking Group at Wells Fargo from October 2020 to June 2024, where she advised biopharmaceutical companies on financing and strategic transactions. Her career experience includes additional investment banking and operational experience at Deutsche Bank, where she was a director in healthcare investment banking from July 2017 to October 2020, Intercept Pharmaceuticals, Citigroup, and Cowen. Her transaction experience includes M&amp;A, IPOs and other equity and debt financings in the healthcare sector with an aggregate transaction value in excess of $50 billion. She received a B.A. in finance from Southern Methodist University.</span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In connection with Ms. To&#8217;s appointment, Ms. To and the Company entered into an employment agreement dated July 26, 2024 (the &#8220;Employment Agreement&#8221;), providing for (i) an annual base salary of $475,000; (ii) a one-time deferred signing bonus in the amount of $125,000, subject to certain conditions; (iii) eligibility to participate in the Company's annual discretionary bonus plan for executives, with the potential to earn a cash bonus of up to forty (45%) percent of Ms. To&#8217;s base salary; (iv) eligibility to participate in the Company&#8217;s benefit plans; (v) reimbursement for reasonable out-of-pocket expenses; and (vi) options to acquire 125,000 shares of the Company&#8217;s common stock, par value $0.0001 per share (the &#8220;Options&#8221;) subject to a four-year vesting schedule with 25% of the Options vesting on the one-year anniversary date from Ms. To&#8217;s start date, and the remaining 75% vesting on a monthly basis thereafter in thirty-six equal installments. The Employment Agreement subjects Ms. To to standard restrictive covenants for agreements of its type, including non-competition and non-solicitation.</span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">There are no arrangements or understandings between Ms. To and any other persons pursuant to which Ms. To was selected as Chief Financial Officer. There are no family relationships between Ms. To and the directors, nor between Ms. To and any executive officer, of the Company. There is no related transaction that would be required to be disclosed with respect to Ms. To pursuant to Item 404(a) of Regulation S&#8209;K.</span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The above description of the Employment Agreement is a summary only and is qualified in its entirety by the full text of the Employment Agreement, a copy of which is attached hereto as Exhibit 10.1 and is incorporated herein by reference.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In connection with Ms. To&#8217;s appointment, Mark Conley, who has been serving as Interim Chief Financial Officer since June 4, 2024, will reassume his prior position as the Company&#8217;s Vice President of Finance.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Item 7.01 Regulation FD Disclosure.</span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On July 31, 2024, the Company issued a press release, a copy of which is filed herewith as Exhibit 99.1, announcing the appointment of Ms. To. The information set forth in this Item 7.01 and in Exhibit 99.1 is furnished and shall not be deemed &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), or otherwise subject to the liabilities of that section. The information in this Item 7.01 and in Exhibit 99.1 shall not be deemed to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date hereof, except as shall be expressly set forth by specific reference in such a filing.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Item 9.01 Financial Statements and Exhibits.</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:13.8%;"/>
    <td style="width:86.2%;"/>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Exhibit Number</span></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Description</span></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">10.1</span></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="sabs-ex10_1.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;min-width:fit-content;">Employment Agreement between SAB Biotherapeutics, Inc. and Lucy To dated July 26, 2024</span></a></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">99.1</span></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="sabs-ex99_1.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;min-width:fit-content;">Press Release of the Company, dated July 31, 2024</span></a></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">104</span></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Cover Page Interactive Data File-the cover page XBRL tags are embedded within the Inline XBRL document.</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <div class="page-node-content"><div style="flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;"></div></div>
  <hr style="page-break-after:always;"/>
  <div style="min-height:0.5in;"></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:9.35pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">SIGNATURES</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:9.35pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:6%;"/>
    <td style="width:44%;"/>
    <td style="width:4%;"/>
    <td style="width:46%;"/>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:4.3pt;font-family:Times New Roman;margin-bottom:4.3pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">SAB Biotherapeutics, Inc.</span></p></td>
   </tr>
   <tr style="word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:4.3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Date:</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:4.3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">July 31, 2024</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:4.3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">By:</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;border-bottom:0.25pt solid;"><p style="font-size:10pt;margin-top:4.3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-style:italic;min-width:fit-content;">/s/ Samuel J. Reich</span></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0.7pt;font-family:Times New Roman;margin-bottom:9.35pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Samuel J. Reich<br/>Chief Executive Officer</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <div class="page-node-content"><div style="flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;"></div></div>
  <hr style="page-break-after:always;"/>
 </body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>sabs-ex10_1.htm
<DESCRIPTION>EX-10.1
<TEXT>
<html>
 <head>
  <title>EX-10.1</title>
 </head>
 <body style="margin: auto!important;padding: 8px;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">Exhibit 10.1</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">EMPLOYMENT AGREEMENT</font></p>
  <p style="margin-left:0.933%;text-indent:6.63%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;margin-right:1.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">This Employment Agreement (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Agreement</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;) is dated July 26, 2024 (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Effective Date</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;), by and between </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">SAB BIOTHERAPEUTICS, INC.</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, a Delaware corporation (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Company</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;), and </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Lucy To</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Executive</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;).</font></p>
  <p style="margin-left:0.933%;text-indent:6.622%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;margin-right:1.213%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">WHEREAS, the Company desires that the Executive join the Company to serve in the capacity of Chief Financial Officer of the Company, and the Executive has agreed to serve in such position in accordance with the terms and conditions of this Agreement;</font></p>
  <p style="margin-left:0.933%;text-indent:6.622%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;margin-right:1.213%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">NOW, THEREFORE, in consideration of the premises and mutual covenants contained herein, and for other valuable consideration, the Company and the Executive hereby agree as follows:</font></p>
  <div class="item-list-element-wrapper" style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:2.4%;text-indent:0;display:inline-flex;justify-content:flex-start;">1.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Certain Definitions</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.  The following terms, as used herein, have the following meanings:</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(a)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Board</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; means the Board of Directors of the Company.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(b)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Cause</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; means one or more of the following: (i) the Executive&#x2019;s willful failure to perform her duties hereunder or the lawful directives of the Board or nominees thereof (other than as a result of illness or injury), (ii) the conviction of, or plea of </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">nolo contendere </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">by, the Executive to, a felony or a crime involving moral turpitude, (iii) the Executive&#x2019;s commission of any willful acts of personal dishonesty in connection with her responsibilities to the Company that could reasonably be expected to materially impair or damage the property, goodwill, reputation, business or finances of the Company, (iv) the Executive&#x2019;s willful and material violation of the Company&#x2019;s policies regarding ethics or conduct (including sexual harassment and other similar policies) that could reasonably be expected to impair or damage the property, goodwill, reputation, business or finances of the Company or its affiliates or (v) the Executive&#x2019;s breach of her obligations under the Confidentiality Agreement.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(c)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Change of Control</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; means the occurrence of any of the following events: (i) a change in the ownership of the Company which occurs on the date that any one person or entity, or more than one person or entity acting as a group (collectively, a &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Person</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; for purposes of this definition), acquires ownership of the stock of the Company that, together with the stock held by such Person, constitutes more than fifty percent (50%) of the total voting power of the stock of the Company; (ii) a change in the effective control of the Company which occurs on the date that a majority of members of the Board is replaced during any twelve (12) month period by Directors whose appointment or election is not endorsed by a majority of the members of the Board prior to the date of the appointment or election; or (iii) change in the ownership of a substantial portion of the Company&#x2019;s assets which occurs on the date that any Person acquires (or has acquired during the twelve (12) month period ending on the date of the most recent acquisition by such Person or Persons) assets from the Company that have a total gross fair market value equal to or more than fifty percent (50%) of the total gross fair market value of all of the assets of the Company immediately prior to such acquisition or acquisitions; provided, however, that for purposes of this subsection (iii), the following will not constitute a change in the ownership of a substantial portion of the Company&#x2019;s assets: (A) a transfer to an entity that is controlled by the Company&#x2019;s stockholders immediately after the transfer, or (B) a transfer of assets by the Company to: (1) a stockholder of the Company (immediately before the asset transfer) in exchange for or with respect to the Company&#x2019;s stock, or (2) an entity, fifty percent (50%) or more of the total value or voting power of which is owned, directly or </font></div></div>
  <div class="page-node-content"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Arial;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></div>
  <div class="item-list-element-wrapper" style="font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">indirectly, by the Company.  For purposes of this subsection (iii), gross fair market value means the value of the assets of the Company, or the value of the assets being disposed of, determined without regard to any liabilities associated with such assets.  For purposes of this definition, Persons will be considered to be acting as a group if they are owners of a corporation that enters into a merger, consolidation, purchase or acquisition of stock, or similar business transaction with the Company.  Notwithstanding the foregoing, a transaction will not be deemed a Change of Control unless the transaction qualifies as a change in control event within the meaning of Code Section 409A, as it has been and may be amended from time to time, and any proposed or final Treasury Regulations and Internal Revenue Service guidance that has been promulgated or may be promulgated thereunder from time to time.  Further and for the avoidance of doubt, a transaction will not constitute a Change of Control if: (i) its sole purpose is to change the state of the Company&#x2019;s incorporation, or (ii) its sole purpose is to create a holding company that will be owned in substantially the same proportions by the persons who held the Company&#x2019;s securities immediately before such transaction.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(d)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Change of Control Period</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; means the twelve (12) month period following a Change of Control.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(e)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Date of Termination</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; means the date specified in a written notice of termination delivered pursuant to </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Section 6</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, or the Executive&#x2019;s last date as an active employee of the Company before a termination of employment due to her death or Non-Renewal.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(f)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Designated Location</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; means the home office of the Executive; provided that Executive will travel to Miami, Florida and Sioux Falls, South Dakota on a regular basis as needed to perform her obligations as the Company&#x2019;s Chief Financial Officer.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(g)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Disabled</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; or &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Disability</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; means a mental or physical condition that renders the Executive substantially incapable of performing her duties and obligations under this Agreement, after taking into account provisions for reasonable accommodation, as determined by a medical doctor (such doctor to be mutually determined in good faith by the parties) for four (4) or more consecutive months or for a total of four (4) months during any twelve (12) consecutive months.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(h)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Good Reason</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; means, unless the Executive has consented in writing thereto, the occurrence of any of the following: (i) the assignment to the Executive of any duties materially inconsistent with the Executive&#x2019;s position, including any change in status, title, authority, duties, non-temporary change in reporting line to anyone other than the Chief Executive Officer of the Company, or responsibilities or any other action which results in a material diminution in such status, title, authority, duties or responsibilities, (ii) a material reduction in the Executive&#x2019;s Base Salary by the Company or (iii) the relocation of the Executive&#x2019;s office to a location more than fifty (50) miles from the Designated Location.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:2.4%;text-indent:0;display:inline-flex;justify-content:flex-start;">2.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Term of Employment</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.  The Executive will start her employment with the Company, upon the terms and conditions set forth in this Agreement for the period commencing on a date to be agreed upon the Company and the Executive, which will be no later than August 19, 2024, and ending on the earlier of: (a) December 31, 2024 (subject to extension as provided in the following sentence) and (b) the Executive&#x2019;s Date of Termination (such period, including any extension as provided below, shall be referred to as the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Term of Employment</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;).  This Agreement and the Term of Employment shall be automatically extended for successive additional one (1)-year terms, unless either party provides written notice of non-renewal at least ninety (90) days before the end of then-current Term of Employment.  The </font></div></div>
  <div class="page-node-content"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></div>
  <div class="item-list-element-wrapper" style="font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Executive agrees to sign all documentation evidencing the foregoing as may be presented to the Executive for signature by the Company.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:2.4%;text-indent:0;display:inline-flex;justify-content:flex-start;">3.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Executive&#x2019;s Duties and Obligations</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(a)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Duties</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.  The Executive shall serve as the Company&#x2019;s Chief Financial Officer.  The Executive shall be responsible for all duties customarily associated with the Chief Financial Officer of a publicly traded company.  The Executive shall report to the Chief Executive Officer of the Company and shall be subject to reasonable policies established by the Chief Executive Officer or the Board.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(b)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Location of Employment</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.  The Executive&#x2019;s principal place of business shall be at the Designated Location.  In addition, the Executive acknowledges and agrees that the performance by the Executive of the Executive&#x2019;s duties shall require travel including, without limitation, overseas travel from time to time.  It is understood that Executive will be working predominantly out of the Designated Location unless the Executive and the Company agree to an alternative arrangement.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(c)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Confidential Information, Assignment of Rights, Non-Solicitation and Non-Competition Agreement</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.  In consideration of the covenants contained herein, the Executive has executed and agrees to be bound by the Confidential Information, Assignment of Rights, Non-Solicitation and Non-Competition Agreement (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Confidentiality Agreement</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;) attached to this Agreement as </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Exhibit A</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.  The Executive shall comply at all times with the covenants (including covenants not to compete or solicit employees, consultants and independent contractors) and other terms and conditions of the Confidentiality Agreement and all other reasonable policies of the Company governing its confidential and proprietary information.  The Executive&#x2019;s obligations under the Confidentiality Agreement shall survive the Term of Employment.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:2.4%;text-indent:0;display:inline-flex;justify-content:flex-start;">4.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Devotion of Time to the Company&#x2019;s Business.  Executive will devote substantially all of her business time and best efforts to the performance of her duties hereunder; provided, however, that Executive shall be allowed, to the extent that such activities do not interfere with the performance of her duties and responsibilities hereunder and do not conflict with the financial, fiduciary or other interests of the Company, as determined in the sole discretion of the Chief Executive Officer of the Company, to manage her passive personal investments and to serve on corporate, civic, charitable and industry boards or committees. Notwithstanding the foregoing, Executive agrees that she shall only serve on for-profit boards of directors or for-profit advisory committees if such service is approved in advance in the sole discretion of the Chief Executive Officer of the Company. </font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:2.4%;text-indent:0;display:inline-flex;justify-content:flex-start;">5.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Compensation and Benefits</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(a)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Base Salary</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.  The Company shall pay to the Executive in accordance with its normal payroll practices (but not less frequently than monthly) an annual salary at a rate of four hundred and seventy five thousand dollars ($475,000) per annum (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Base Salary</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;).  The Executive&#x2019;s Base Salary shall be reviewed annually for the purpose of determining increases, if any, based on the Executive&#x2019;s performance, the performance of the Company, then prevailing salary scales for comparable positions, inflation and other relevant factors.  Effective as of the date of any increase in the Executive&#x2019;s Base Salary, Base Salary as so increased shall be considered the new Base Salary for all purposes of this Agreement and may not thereafter </font></div></div>
  <div class="page-node-content"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></div>
  <div class="item-list-element-wrapper" style="font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">be reduced.  Any increase in Base Salary shall not limit or reduce any other obligation of the Company to the Executive under this Agreement.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(b)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Deferred Signing Bonus</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.  So long as the Executive remains an employee in good standing through October 31, 2024, the Executive will be eligible to receive a one-time signing bonus in the amount of one hundred and twenty five thousand dollars ($125,000); provided that such deferred signing bonus will be paid only after the Company closes one or more new equity financings which result in aggregate net proceeds to the Company of at least twenty million dollars ($20,000,000).</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(c)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Annual Bonus</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.  During the Term of Employment, the Executive shall be eligible to receive an annual cash incentive award (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Annual Bonus</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;) pursuant to the bonus plan then in effect for Executive employees of the Company (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Bonus Plan</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;).  All Annual Bonuses are subject to the terms and conditions of then-current Bonus Plan adopted by the Company.  If the Executive achieves her target performance goals for a calendar year, which goals shall be determined by the Compensation Committee of the Board on an annual or more frequent basis, the Annual Bonus shall be targeted at forty five percent (45%) of the Executive&#x2019;s Base Salary.  </font><font style="color:#212121;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Based on achievement of agreed upon Company and personal goals, the Annual Bonus may be less than or exceed this target.  </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">To be eligible to receive an Annual Bonus, or any portion thereof, the Executive must be actively employed by the Company at the time the Annual Bonus, if any, is paid, except as otherwise provided below.  The Annual Bonus for the year ending December 31, 2024, will be prorated.  Any future Annual Bonus that covers less than a full calendar year may be subject to proration.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(d)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Equity Awards</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.  As soon as practicable following the Effective Date, and subject to approval of the Compensation Committee of the Board (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Compensation Committee</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;), the Executive shall receive a grant of options to purchase up to 125,000 shares of common stock of the Company (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Award</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;) under the SAB Biotherapeutics, Inc. 2021 Omnibus Equity Incentive Plan (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Equity Plan</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;).  The terms and conditions of the Award shall be documented in a corresponding stock option award agreement between the Company and the Executive.  The Award will vest over four years with 25% of the Award vesting on the one-year anniversary of the Effective Date and the remaining 75% of the Award vesting on a monthly basis in thirty-six equal installments.  From time to time, the Executive may receive additional equity incentive awards under the Equity Plan (or under any other equity incentive plan adopted by the Company to supplement or succeed the Equity Plan with the Award, &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Equity Awards</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;) subject to such terms and conditions as the Compensation Committee, in its sole discretion, may determine.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(e)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Benefits</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.  During the Term of Employment, the Executive shall be entitled to participate in all employee benefit plans, programs and arrangements made available generally to the Company&#x2019;s senior employees or to other full-time employees on substantially the same basis that such benefits are provided to such senior employees of a similar level or to other full-time employees.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(f)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Vacations</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.  During the Term of Employment, the Executive shall be entitled to twenty (20) days paid vacation per year, or such greater amount as may be earned under the Company&#x2019;s standard vacation policy.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(g)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Reimbursement of Expenses</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.  During the Term of Employment, the Executive shall be entitled to receive prompt reimbursement for all reasonable business-related or employment-related expenses incurred by the Executive upon the receipt by the Company </font></div></div>
  <div class="page-node-content"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></div>
  <div class="item-list-element-wrapper" style="font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">of reasonable documentation in accordance with standard practices, policies and procedures applicable to other senior employees of the Company, provided that the Executive shall be entitled to travel business class (if available) on flights longer than six (6) hours in duration provided that such ticket can be obtained for a reasonable cost. If a flight is between five (5) and six (6) hours and departs after 9pm local time, Executive shall be entitled to travel business class provided that such ticket can be obtained for a reasonable cost.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:2.4%;text-indent:0;display:inline-flex;justify-content:flex-start;">6.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Termination of Employment</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.  The Term of Employment shall be automatically terminated upon the first to occur of the following:</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(a)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Death</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.  The Executive&#x2019;s employment shall terminate immediately upon the Executive&#x2019;s death.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(b)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Disability</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.  If the Executive is Disabled, either party may terminate the Executive&#x2019;s employment due to such Disability upon delivery of written notice to the other party.  The effective date of such termination of employment will be the Date of Termination set forth in such written notice or immediately upon delivery of such written notice if no effective date is specified in the written notice.  For avoidance of doubt, if the Executive&#x2019;s employment is terminated pursuant to this </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Section 6(b)</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, her employment will not constitute a termination of employment by the Company without Cause or by the Executive for Good Reason.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(c)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Termination by the Executive Without Good Reason</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.  The Executive may terminate her employment for any reason other than Good Reason upon her delivery of written notice to the Company at least thirty (30) days prior to her Date of Termination.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(d)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Termination by the Executive for Good Reason</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.  The Executive may terminate her employment for Good Reason if (i) not later than ninety (90) days after the occurrence of any act or omission that constitutes Good Reason, the Executive provides the Company with a written notice setting forth in reasonable detail the acts or omissions that constitute Good Reason, (ii) the Company fails to correct or cure the acts or omissions within thirty (30) days after it receives such written notice, and (iii) the Executive terminates her employment with the Company after the expiration of such cure period but not later than thirty (30) days after the expiration of such cure period.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(e)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Termination by the Company Without Cause</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.  The Company may terminate the Executive&#x2019;s employment without Cause upon delivery of written notice to the Executive at least fifteen (15) days prior to her Date of Termination. </font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(f)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Termination Upon Non-Renewal</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.  Unless otherwise agreed to by the parties, the Executive&#x2019;s employment shall terminate on the last day of then-current Term of Employment if either the Company or the Executive provides the other party with a written notice of non-renewal of this Agreement in accordance with </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Section 2</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> and the parties do not enter into a new employment agreement prior to the expiration of this Agreement (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Non-Renewal</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;).</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(g)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Termination by the Company for Cause</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.  Upon the occurrence of any act or omission that constitutes Cause, the Company may terminate the Executive&#x2019;s employment upon delivery of written notice to the Executive at least fifteen (15) days prior to her Date of Termination, unless the Executive cures, if curable, such acts or omissions constituting Cause to the satisfaction of the Company prior to the expiration of such period.</font></div></div>
  <div class="page-node-content"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></div>
  <div class="item-list-element-wrapper" style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:2.4%;text-indent:0;display:inline-flex;justify-content:flex-start;">7.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Compensation and Benefits Payable Upon of Termination of Employment Unrelated to a Change of Control</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(a)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Payment of Accrued but Unpaid Compensation and Benefits</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.  Upon the Executive&#x2019;s termination of employment for any reason outside of the Change of Control Period, the Executive (or her Beneficiary following the Executive&#x2019;s death) shall receive (i) a lump sum payment on the Date of Termination in an amount equal to the sum of the Executive&#x2019;s earned but unpaid Base Salary through her Date of Termination plus her accrued but unused vacation days at the Executive&#x2019;s Base Salary in effect as of her Date of Termination; plus (ii) any other benefits or rights the Executive has accrued or earned through her Date of Termination in accordance with the terms of the applicable fringe or employee benefit plans and programs of the Company.  Except as provided in </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Section 7(b)</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> or </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Section 7(c)</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> below or as expressly provided pursuant to the terms of any employee benefit plan, the Executive will not be entitled to earn or accrue any additional compensation or benefits for any period following her Date of Termination.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(b)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Termination of Employment Due to Death or Disability</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.  In addition to the compensation and benefits payable under </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Section 7(a)</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> above, if the Executive&#x2019;s employment is terminated due to her death or Disability outside of the Change of Control Period, the Executive (or her Beneficiary following the Executive&#x2019;s death) shall receive:</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:20%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:20%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:2.667%;text-indent:0;display:inline-flex;justify-content:flex-start;">(i)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">the Executive&#x2019;s accrued but unpaid Annual Bonus, if any, for the calendar year ended prior to her Date of Termination payable at the same time annual bonuses for such calendar year are paid to other senior employees of the Company pursuant to the terms of the Bonus Plan; and</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:20%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:20%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:2.667%;text-indent:0;display:inline-flex;justify-content:flex-start;">(ii)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">reimbursement of the COBRA premiums, if any, paid by the Executive&#x2019;s spouse and dependents for continuation coverage for the Executive&#x2019;s spouse and dependents under the Company&#x2019;s group health, dental and vision plans for a six (6) month period from the Date of Termination.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(c)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Termination of Employment by the Company Without Cause, by the Executive for Good Reason or Upon Non-Renewal by the Company</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.  In addition to the compensation and benefits payable under </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Section 7(a)</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> above, if the Executive&#x2019;s employment is terminated by the Company without Cause, by the Executive for Good Reason or upon Non-Renewal where it is the Company that provided written notice of non-renewal of this Agreement in accordance with </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Section 2</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, and such termination occurs outside of the Change of Control Period, and the Executive returns an executed Release to the Company, which becomes final, binding and irrevocable within sixty (60) days following the Executive&#x2019;s Date of Termination in accordance with </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Section 10</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, the Executive (or her Beneficiary following the Executive&#x2019;s death) shall receive:</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:20%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:20%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:2.667%;text-indent:0;display:inline-flex;justify-content:flex-start;">(i)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">the Executive&#x2019;s accrued but unpaid Annual Bonus, if any, for the calendar year ended prior to her Date of Termination payable at the same time annual bonuses for such calendar year are paid to other senior employees of the Company pursuant to the terms of the Bonus Plan;</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:20%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:20%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:2.667%;text-indent:0;display:inline-flex;justify-content:flex-start;">(ii)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">One hundred percent (100%) of the Executive&#x2019;s outstanding unvested Equity Awards as of the Date of Termination will be fully vested and exercisable;</font></div></div>
  <div class="page-node-content"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></div>
  <div class="item-list-element-wrapper" style="text-indent:20%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:20%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:2.667%;text-indent:0;display:inline-flex;justify-content:flex-start;">(iii)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">a severance payment payable in a single lump sum within five (5) business days after the Executive&#x2019;s Release becomes final, binding and irrevocable in accordance with </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Section 10</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, in an amount equal to twelve (12) months of Base Salary; and</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:20%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:20%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:2.667%;text-indent:0;display:inline-flex;justify-content:flex-start;">(iv)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">reimbursement of the COBRA premiums, if any, paid by the Executive for continuation coverage for the Executive, her spouse and dependents under the Company&#x2019;s group health, dental and vision plans for a six (6) month period from the Date of Termination.</font></div></div>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Notwithstanding the foregoing, if the Executive materially breaches this Agreement or the Executive&#x2019;s Confidentiality Agreement, then the Company&#x2019;s continuing obligations under this </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Section 7(c)</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> shall cease as of the date of the breach and the Executive shall be entitled to no further payments hereunder.</font></p>
  <div class="item-list-element-wrapper" style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:2.4%;text-indent:0;display:inline-flex;justify-content:flex-start;">8.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Termination of Employment by the Company Without Cause, by the Executive for Good Reason or Upon Non-Renewal by the Company in Connection with a Change of Control</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.  In addition to the compensation and benefits payable under </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Section 7(a)</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> above, if the Executive&#x2019;s employment is terminated by the Company without Cause, by the Executive for Good Reason or upon Non-Renewal where it is the Company that provided written notice of non-renewal of this Agreement in accordance with </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Section 2</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, and such termination occurs during the Change of Control Period, and the Executive returns an executed Release to the Company, which becomes final, binding and irrevocable within sixty (60) days following the Executive&#x2019;s Date of Termination in accordance with </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Section 10</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, the Executive (or her Beneficiary following the Executive&#x2019;s death) shall receive:</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(a)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">a single lump sum within five (5) business days after the Executive&#x2019;s Release becomes final, binding and irrevocable in accordance with </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Section 10</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, equal to the Executive&#x2019;s accrued but unpaid Annual Bonus, if any, for the calendar year ended prior to her Date of Termination;</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(b)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">a single lump sum within five (5) business days after the Executive&#x2019;s Release becomes final, binding and irrevocable in accordance with </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Section 10</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, equal to one hundred percent (100%) of Executive&#x2019;s target bonus as in effect for the calendar year in which Executive&#x2019;s termination of employment occurs; provided that the amount paid to Executive pursuant to this </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Section 8(b)</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> will be prorated based on the actual amount of time Executive is employed by the Company during the calendar year (or the relevant performance period if something different than a calendar year) during which the termination occurs;</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(c)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">one hundred percent (100%) of the Executive&#x2019;s outstanding unvested Equity Awards as of the Date of Termination will be fully vested and exercisable;</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(d)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">a severance payment payable in a single lump sum within five (5) business days after the Executive&#x2019;s Release becomes final, binding and irrevocable in accordance with </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Section 10</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, in an amount equal to eighteen (18) months of Base Salary; and </font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(e)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">reimbursement of the COBRA premiums, if any, paid by the Executive for continuation coverage for the Executive, her spouse and dependents under the Company&#x2019;s group health, dental and vision plans for a twelve (12) month period from the Date of Termination.</font></div></div>
  <div class="page-node-content"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></div>
  <div class="item-list-element-wrapper" style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:2.4%;text-indent:0;display:inline-flex;justify-content:flex-start;">9.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Terminations Within Sixty (60) Days Prior to a Change of Control</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.  If (a) the Executive incurred a termination prior to a Change of Control that qualifies Executive for severance payments under </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Section 7(c)</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> and (b) a Change of Control occurs within sixty (60) days following Executive&#x2019;s termination of employment, then upon the Change of Control, the Executive shall be entitled to a lump-sum payment of the amount calculated under this </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Section 8</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, less amounts already paid under </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Section 7(c)</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, subject to compliance with </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Section 10</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:2.4%;text-indent:0;display:inline-flex;justify-content:flex-start;">10.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Release</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.  As a condition of receiving the compensation and benefits described in </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Section 7(c)</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> or </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Section 8</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, the Executive must execute a release of any and all claims arising out of the Executive&#x2019;s employment with the Company or the Executive&#x2019;s separation from such employment (including, without limitation, claims relating to age, disability, sex or race discrimination to the extent permitted by law), excepting (i) claims for benefits under any employee benefit plan in accordance with the terms of such employee benefit plan, (ii) any right to exercise Equity Awards that are vested on the Date of Termination pursuant to the terms of such Equity Awards (as modified by the Employment Agreement), (iii) claims based on breach of the Company&#x2019;s obligations to pay the compensation and benefits described in </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Section 5</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> and </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Section 7(a)</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Section 7(c)</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> or </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Section 8</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> of this Employment Agreement, (iv) claims arising under the Age Discrimination in Employment Act after the date the Executive signs such release, and (v) any right to indemnification by the Company or to coverage under directors and officers liability insurance to which the Executive is otherwise entitled in accordance with this Agreement and the Company&#x2019;s articles of incorporation or by laws or other agreement between the Executive and the Company (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Release</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;).  Such Release shall be in a form tendered to the Executive by the Company within five (5) business days following the termination of the Executive&#x2019;s employment by the Company without Cause or by the Executive for Good Reason, which shall comply with any applicable legislation or judicial requirements, including, but not limited to, the Older Workers Benefit Protection Act, and shall be substantially in the form of release attached as </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Exhibit B</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.  The compensation and benefits described in </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Section 7(c)</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> or </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Section 8</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> will not be paid to the Executive if the Executive fails to execute the Release within the time frame specified in such Release, if the Executive revokes the Release within the applicable revocation period set forth in such Release or if the revocation period expires more than sixty (60) days following the Executive&#x2019;s Date of Termination.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:2.4%;text-indent:0;display:inline-flex;justify-content:flex-start;">11.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Excess Parachute Excise Tax</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(a)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Anything in this Agreement to the contrary notwithstanding, in the event it shall be determined that any payment, award, benefit or distribution (including any acceleration) by the Company or any entity which effectuates a transaction described in Section 280G(b)(2)(A)(i) of the Internal Revenue Code of 1986, as amended and the regulations promulgated thereunder (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Code</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;) to or for the benefit of the Executive (whether pursuant to the terms of this Agreement or otherwise, but determined before application of any reductions required pursuant to this </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Section 11</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">) (a &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Payment</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;) would be subject to the excise tax imposed by Section 4999 of the Code or any interest or penalties are incurred with respect to such excise tax by the Executive (such excise tax, together with any such interest and penalties, are hereinafter collectively referred to as the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Excise Tax</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;), the Company will automatically reduce such Payments to the extent, but only to the extent, necessary so that no portion of the remaining Payments will be subject to the Excise Tax, unless the amount of such Payments that the Executive would retain after payment of the Excise Tax and all applicable Federal, state and local income taxes without such reduction would exceed the amount of such Payments that the Executive would retain after payment of all applicable Federal, state and local taxes after applying such reduction.  Unless otherwise elected by the Executive, to the </font></div></div>
  <div class="page-node-content"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></div>
  <div class="item-list-element-wrapper" style="font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">extent permitted under Code Section 409A, such reduction shall first be applied to any severance payments payable to the Executive under this Agreement, then to the accelerated vesting on any Equity Awards.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(b)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">All determinations required to be made under this </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Section 11</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, including the assumptions to be utilized in arriving at such determination, shall be made by the Company&#x2019;s independent auditors or such other certified public accounting firm of national standing reasonably acceptable to the Executive as may be designated by the Company (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Accounting Firm</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;) which shall provide detailed supporting calculations both to the Company and the Executive within fifteen (15) business days of the receipt of notice from the Executive that there has been a Payment, or such earlier time as is requested by either the Company or the Executive.  All fees and expenses of the Accounting Firm shall be borne solely by the Company.  If the Accounting Firm determines that no Excise Tax is payable by the Executive, it shall furnish the Executive with a written opinion to such effect.  Any determination by the Accounting Firm shall be binding upon the Company and the Executive.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:2.4%;text-indent:0;display:inline-flex;justify-content:flex-start;">12.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Legal Fees</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.  Each party shall be responsible for its own legal fees and expenses in connection with any claim or dispute relating to this Agreement.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:2.4%;text-indent:0;display:inline-flex;justify-content:flex-start;">13.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Beneficiary</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.  If the Executive dies prior to receiving all of the amounts payable to her in accordance with the terms of this Agreement, such amounts shall be paid to one or more beneficiaries (each, a &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Beneficiary</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;) designated by the Executive in writing to the Company during her lifetime, or if no such Beneficiary is designated, to the Executive&#x2019;s estate.  Such payments shall be made in accordance with the terms of this Agreement.  The Executive, without the consent of any prior Beneficiary, may change her designation of Beneficiary or Beneficiaries at any time or from time to time by a submitting to the Company a new designation in writing.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:2.4%;text-indent:0;display:inline-flex;justify-content:flex-start;">14.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Notices</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.  All notices, requests, demands and other communications hereunder shall be in writing and shall be deemed to have been duly given if delivered by hand, email or mailed within the continental United States by first class certified mail, return receipt requested, postage prepaid, addressed as follows:</font></div></div>
  <p style="margin-left:7.427%;text-indent:-16.201%;padding-left:6.493%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;margin-right:46%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">If to the Company:</font></p>
  <p style="margin-left:13.92%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:1.296%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">SAB Biotherapeutics, Inc.</font></p>
  <p style="margin-left:13.92%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:1.296%;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:13.92%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:1.296%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Attn:  Chief Executive Officer</font></p>
  <p style="margin-left:13.92%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;margin-right:1.296%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Email:</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">  </font></p>
  <p style="margin-left:7.427%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;margin-right:1.463%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">If to the Executive:</font></p>
  <p style="margin-left:13.92%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;margin-right:1.463%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">To the address on file with the records of the Company.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Addresses may be changed by written notice sent to the other party at the last recorded address of that party.</font></p>
  <div class="item-list-element-wrapper" style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:2.4%;text-indent:0;display:inline-flex;justify-content:flex-start;">15.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Withholding</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.  The Company shall be entitled to withhold from payments due hereunder any required federal, state or local withholding or other taxes.</font></div></div>
  <div class="page-node-content"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></div>
  <div class="item-list-element-wrapper" style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:2.4%;text-indent:0;display:inline-flex;justify-content:flex-start;">16.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Arbitration</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(a)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">If the parties are unable to resolve any dispute or claim relating directly or indirectly to this agreement or any dispute or claim between the Executive and the Company or its officers, directors, agents, or employees (a &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Dispute</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;), then either party may require the matter to be settled by final and binding arbitration by sending written notice of such election to the other party clearly marked &#x201c;Arbitration Demand.&#x201d; Thereupon such Dispute shall be arbitrated in accordance with the terms and conditions of this </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Section 16</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.  Notwithstanding the foregoing, either party may apply to a court of competent jurisdiction for a temporary restraining order, a preliminary injunction, or other equitable relief to preserve the status quo or prevent irreparable harm or to enforce the terms of the Confidentiality Agreement.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(b)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">The Dispute shall be resolved by a single arbitrator in an arbitration administered by the American Arbitration Association in accordance with its Employment Arbitration Rules and judgment upon the award rendered by the arbitrator may be entered in any court having jurisdiction thereof.  The decision of the arbitrator shall be final and binding on the parties, and specific performance giving effect to the decision of the arbitrator may be ordered by any court of competent jurisdiction.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(c)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Nothing contained herein shall operate to prevent either party from asserting counterclaim(s) in any arbitration commenced in accordance with this Agreement, and any such party need not comply with the procedural provisions of this </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Section 16</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> in order to assert such counterclaim(s).</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(d)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">The arbitration shall be filed with the office of the American Arbitration Association (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">AAA</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;) located in South Dakota or such other AAA office as the parties may agree upon (without any obligation to so agree).  The arbitration shall be conducted pursuant to the Employment Arbitration Rules of the AAA as in effect at the time of the arbitration hearing, such arbitration to be completed in a sixty (60)-day period.  In addition, the following rules and procedures shall apply to the arbitration:</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(e)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">The arbitrator shall have the sole authority to decide whether or not any Dispute between the parties is arbitrable and whether the party presenting the issues to be arbitrated has satisfied the conditions precedent to such party&#x2019;s right to commence arbitration as required by this </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Section 16</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(f)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">The decision of the arbitrator, which shall be in writing and state the findings, the facts and conclusions of law upon which the decision is based, shall be final and binding upon the parties, who shall forthwith comply after receipt thereof.  Judgment upon the award rendered by the arbitrator may be entered by any competent court.  Each party submits itself to the jurisdiction of any such court, but only for the entry and enforcement to judgment with respect to the decision of the arbitrator hereunder.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(g)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">The arbitrator shall have the power to grant all legal and equitable remedies (including, without limitation, specific performance) and award compensatory and punitive damages if authorized by applicable law.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(h)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Except as otherwise provided in </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Section 12</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> or by law, the parties shall bear their own costs in preparing for and participating in the resolution of any Dispute pursuant to this </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Section 16</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, and the costs of the arbitrator(s) shall be equally divided between the parties.</font></div></div>
  <div class="page-node-content"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></div>
  <div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(i)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Except as provided in the last sentence of </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Section 16(a)</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">, the provisions of this </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Section 16</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> shall be a complete defense to any suit, action or proceeding instituted in any federal, state or local court or before any administrative tribunal with respect to any Dispute arising in connection with this Agreement.  Any party commencing a lawsuit in violation of this </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Section 16</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> shall pay the costs of the other party, including, without limitation, reasonable attorney&#x2019;s fees and defense costs.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:2.4%;text-indent:0;display:inline-flex;justify-content:flex-start;">17.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Recoupment</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(a)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Policy</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.  Any incentive-based compensation received by the Executive including Annual Bonus and Equity Awards, whether pursuant to this Agreement or otherwise, that is granted, earned or vested based in any part on attainment of a financial reporting measure, shall be subject to the terms and conditions of the Company&#x2019;s Claw Back Compensation Policy (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Recoupment Policy</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;), and any other policy of recoupment of compensation as shall be adopted from time to time by the Board or its Compensation Committee as it deems necessary or appropriate to comply with the requirements of Section 954 of the Dodd-Frank Wall Street Reform and Consumer Protection Act, Section 304 of the Sarbanes-Oxley Act of 2002, and any implementing rules and regulations of the U.S. Securities and Exchange Commission and applicable listing standards of a national securities exchange adopted in accordance with any of the foregoing.  The terms and conditions of the Recoupment Policy, including any changes to the Recoupment Policy adopted from time to time by the Company, are hereby incorporated by reference into this Agreement.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(b)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Non-Indemnification and Advancement for Recoupment</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.  The Company shall not be obligated to indemnify or advance funds to the Executive for any payment or reimbursement by the Executive to the Company of any bonus or other incentive-based or equity-based compensation previously received by the Executive or payment of any profits realized by the Executive from the sale of securities of the Company, as required in each case under the Securities Exchange Act of 1934 or under the rules of the stock exchange on which the common stock of the Company is listed (including any such payments or reimbursements under Section 304 and 306 of the Sarbanes-Oxley Act of 2002, or pursuant to Section 954 of the Dodd-Frank Wall Street Reform and Consumer Protection Act and any implementing rules and regulations of the U.S. Securities and Exchange Commission and applicable listing standards of a national securities exchange adopted in accordance with any of the foregoing).</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:2.4%;text-indent:0;display:inline-flex;justify-content:flex-start;">18.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Miscellaneous</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(a)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Governing Law</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.  This Agreement shall be interpreted, construed, governed and enforced according to the laws of the State of New York without regard to the application of choice of law rules.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(b)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Entire Agreement</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.  This Agreement contains the entire agreement between the parties with respect to the subject matter hereof and supersedes any and all other prior agreements, promises, understandings and representations regarding the Executive&#x2019;s employment, compensation, severance or other payments contingent upon the Executive&#x2019;s termination of employment, whether written or otherwise.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(c)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Amendments</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.  No amendment or modification of the terms or conditions of this Agreement shall be valid unless in writing and signed by the parties hereto.</font></div></div>
  <div class="page-node-content"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></div>
  <div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(d)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Severability</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.  If one or more provisions of this Agreement are held to be invalid or unenforceable under applicable law, such provisions shall be construed, if possible, so as to be enforceable under applicable law, or such provisions shall be excluded from this Agreement and the balance of the Agreement shall be interpreted as if such provision were so excluded and shall be enforceable in accordance with its terms.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(e)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Binding Effect</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.  This Agreement shall be binding upon and inure to the benefit of the beneficiaries, heirs and representatives of the Executive (including the Beneficiary) and the successors and assigns of the Company.  The Company shall require any successor (whether direct or indirect, by purchase, merger, reorganization, consolidation, acquisition of property or stock, liquidation, or otherwise) to all or substantially all of its assets, by agreement in form and substance satisfactory to the Executive, expressly to assume and agree to perform this Agreement in the same manner and to the same extent that the Company would be required to perform this Agreement if no such succession had taken place.  Regardless of whether such agreement is executed, this Agreement shall be binding upon any successor of the Company in accordance with the operation of law and such successor shall be deemed the Company for purposes of this Agreement.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(f)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Successors and Assigns; Non-alienation of Benefits</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.  Except as provided in </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Section 18(e)</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> in the case of the Company, or to the Beneficiary in the case of the death of the Executive, this Agreement is not assignable by any party.  Compensation and benefits payable to the Executive under this Agreement shall not be subject in any manner to anticipation, alienation, sale, transfer, assignment, pledge, encumbrance, charge, garnishment, execution or levy of any kind, either voluntary or involuntary, prior to actually being received by the Executive or a Beneficiary, as applicable, and any such attempt to dispose of any right to benefits payable hereunder shall be void and no payment to be made hereunder shall be subject to anticipation, alienation, sale, transfer, assignment, pledge, encumbrance or other charge.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(g)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Remedies Cumulative; No Waiver</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.  No remedy conferred upon either party by this Agreement is intended to be exclusive of any other remedy, and each and every such remedy shall be cumulative and shall be in addition to any other remedy given hereunder or now or hereafter existing at law or in equity.  No delay or omission by either party in exercising any right, remedy or power hereunder or existing at law or in equity shall be construed as a waiver thereof, and any such right, remedy or power may be exercised by such party from time to time and as often as may be deemed expedient or necessary by such party in such party&#x2019;s sole discretion.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(h)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Survivorship</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.  Notwithstanding anything in this Agreement to the contrary, all terms and provisions of this Agreement that by their nature extend beyond the Date of Termination shall survive termination of this Agreement.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(i)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Counterparts</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.  This Agreement may be executed in two or more counterparts, each of which shall constitute an original, but all of which, when taken together, shall constitute one document.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:2.4%;text-indent:0;display:inline-flex;justify-content:flex-start;">19.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">No Contract of Employment</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.  Nothing contained in this Agreement will be construed as a right of the Executive to be continued in the employment of the Company, or as a limitation of the right of the Company to discharge the Executive with or without Cause.</font></div></div>
  <div class="page-node-content"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></div>
  <div class="item-list-element-wrapper" style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:2.4%;text-indent:0;display:inline-flex;justify-content:flex-start;">20.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Section 409A of the Code</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(a)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">The intent of the parties is that payments and benefits under this Agreement comply with, or be exempt from, Section 409A of the Code and, accordingly, to the maximum extent permitted, this Agreement shall be construed and interpreted in accordance with such intent.  The Executive&#x2019;s termination of employment (or words to similar effect) shall not be deemed to have occurred for purposes of this Agreement unless such termination of employment constitutes a &#x201c;separation from service&#x201d; within the meaning of Code Section 409A and the regulations and other guidance promulgated thereunder.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(b)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Notwithstanding any provision in this Agreement to the contrary, if the Executive is deemed on the date of the Executive&#x2019;s separation from service to be a &#x201c;specified employee&#x201d; within the meaning of that term under Code Section 409A(a)(2)(B) and using the identification methodology selected by the Company from time to time, or if none, the default methodology set forth in Code Section 409A, then with regard to any payment or the providing of any benefit that constitutes &#x201c;non-qualified deferred compensation&#x201d; pursuant to Code Section 409A and the regulations issued thereunder that is payable due to the Executive&#x2019;s separation from service, to the extent required to be delayed in compliance with Code Section 409A(a)(2)(B), such payment or benefit shall not be made or provided to the Executive prior to the earlier of (i) the expiration of the six (6)-month period measured from the date of the Executive&#x2019;s separation from service, and (ii) the date of the Executive&#x2019;s death.  On the first day of the seventh (7</font><font style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:8.040000000000001pt;font-family:Times New Roman;min-width:fit-content;">th</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">) month following the date of the Executive&#x2019;s separation from service or, if earlier, on the date of the Executive&#x2019;s death, all payments delayed pursuant to this </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Section 20</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> shall be paid or reimbursed to the Executive in a lump sum, and any remaining payments and benefits due to the Executive under this Agreement shall be paid or provided in accordance with the normal payment dates specified for them herein.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(c)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">To the extent any reimbursement of costs and expenses (including reimbursement of COBRA premiums pursuant to </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Section 7(c)(iv)</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">) provided for under this Agreement constitutes taxable income to the Executive for Federal income tax purposes, such reimbursements shall be made as soon as practicable after the Executive provides proper documentation supporting reimbursement but in no event later than December 31 of the calendar year next following the calendar year in which the expenses to be reimbursed are incurred.  With regard to any provision herein that provides for reimbursement of expenses or in-kind benefits, except as permitted by Code Section 409A, (i) the right to reimbursement or in-kind benefits is not subject to liquidation or exchange for another benefit, and (ii) the amount of expenses eligible for reimbursement, or in-kind benefits, provided during any taxable year shall not affect the expenses eligible for reimbursement, or in-kind benefits to be provided, in any other taxable year.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:4.8%;text-indent:0;display:inline-flex;justify-content:flex-start;">(d)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">If under this Agreement, any amount is to be paid in two (2) or more installments, each such installment shall be treated as a separate payment for purposes of Section 409A.</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:2.4%;text-indent:0;display:inline-flex;justify-content:flex-start;">21.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Executive Acknowledgement</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.  The Executive hereby acknowledges that the Executive has read and understands the provisions of this Agreement, that the Executive has been given the opportunity for the Executive&#x2019;s legal counsel to review this Agreement, that the provisions of this Agreement are reasonable and that the Executive has received a copy of this Agreement.</font></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">[SIGNATURE PAGE FOLLOWS]</font></p>
  <div class="page-node-content"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></div>
  <p style="text-indent:6.814%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;margin-right:2.157%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">IN WITNESS WHEREOF, the parties hereto have caused this Employment Agreement to be executed as of the 26</font><font style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:8.040000000000001pt;font-family:Times New Roman;min-width:fit-content;">th</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> day of July, 2024.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:36pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">SAB BIOTHERAPEUTICS, INC.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">By:  </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">						</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Name:  Samuel J. Reich</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:24pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Title:  	Chief Executive Officer</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:36pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">EMPLOYEE</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">						</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"><br>Lucy To</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <div class="page-node-content"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Arial;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">EXHIBIT A</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">CONFIDENTIAL INFORMATION, ASSIGNMENT OF RIGHTS,<br>NON-SOLICITATION AND NON-COMPETITION AGREEMENT</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">[SEE ATTACHED]</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <div class="page-node-content"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Arial;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">EXHIBIT B</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">WAIVER AND RELEASE</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">This is a Waiver and Release (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Release</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;) between Lucy To (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Executive</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;) and SAB Biotherapeutics, Inc. (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Company</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;).  The Company and the Executive agree that they have entered into this Release voluntarily, and that it is intended to be a legally binding commitment between them.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">In consideration for and contingent upon the Executive&#x2019;s right to receive the benefits described in the Employment Agreement between the Company and the Executive (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Employment Agreement</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;) and this Release, the Executive hereby agrees as follows:</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">(a)	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">General Waiver and Release</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.  Except as provided in Paragraph (e) below, the Executive and any person acting through or under the Executive hereby release, waive and forever discharge the Company, its past and present subsidiaries and affiliates, and their respective successors and assigns, and their respective past and present officers, trustees, directors, shareholders, employees and agents of each of them, from any and all claims, demands, actions, liabilities and other claims for relief and remuneration whatsoever (including without limitation attorneys&#x2019; fees and expenses), whether known or unknown, absolute, contingent or otherwise (each, a &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Claim</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;), arising or which could have arisen up to and including the date of her execution of this Release, including without limitation those arising out of or relating to the Executive&#x2019;s employment or cessation and termination of employment, or any other written or oral agreement, any change in the Executive&#x2019;s employment status, any benefits or compensation, any tortious injury, breach of contract, wrongful discharge (including any Claim for constructive discharge), infliction of emotional distress, slander, libel or defamation of character, and any Claims arising under Title VII of the Civil Rights Act of 1964 (as amended by the Civil Rights Act of 1991), the Americans With Disabilities Act, the Rehabilitation Act of 1973, the Equal Pay Act, the Older Workers Benefits Protection Act, the Age Discrimination in Employment Act, the Executive Retirement Income Security Act of 1974, or any other federal, state or local statute, law, ordinance, regulation, rule or Executive order, any tort or contract claims, and any of the claims, matters and issues which could have been asserted by the Executive against the Company or its subsidiaries and affiliates in any legal, administrative or other proceeding.  The Executive agrees that if any action is brought in her name before any court or administrative body, the Executive will not accept any payment of monies in connection therewith.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">(b)	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Miscellaneous</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.  the Executive agrees that Section 7(c) of the Employment Agreement (which is specifically incorporated herein by reference) specifies payments from the Company to himself, the total of which meets or exceeds any and all funds due her by the Company, and that she will not seek to obtain any additional funds from the Company with the exception of non-reimbursed business expenses.  (This covenant does not preclude the Executive from seeking workers&#x2019; compensation, unemployment compensation, or benefit payments from the Company&#x2019;s insurance carriers that could be due her.)</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">(c)	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Non-Solicitation, Confidentiality and Non-Solicitation Covenants</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.  the Executive warrants that the Executive has and will comply fully with Section 3(c) of the Employment Agreement and the provisions of the Confidential Information, Assignment of Rights, Non-Solicitation and Non-Competition Agreement by and between the Company and the Executive.</font></p>
  <div class="page-node-content"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">Exhibit B &#x2013; Page </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">1</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Arial;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></div>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">(d)	THE COMPANY AND THE EMPLOYEE AGREE THAT THE BENEFITS DESCRIBED IN SECTION 7(C) OF THE EMPLOYMENT AGREEMENT AS SUBJECT TO EMPLOYEE&#x2019;S COMPLIANCE WITH </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">SECTION 9</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> THEREOF ARE CONTINGENT UPON THE EMPLOYEE SIGNING THIS RELEASE.  THE EMPLOYEE FURTHER UNDERSTANDS AND AGREES THAT IN SIGNING THIS RELEASE, EMPLOYEE IS RELEASING POTENTIAL LEGAL CLAIMS AGAINST THE COMPANY.  THE EMPLOYEE UNDERSTANDS AND AGREES THAT IF HE DECIDES NOT TO SIGN THIS RELEASE, OR IF HE REVOKES THIS RELEASE, THAT HE WILL IMMEDIATELY REFUND TO THE COMPANY ANY AND ALL SEVERANCE PAYMENTS AND OTHER BENEFITS HE MAY HAVE ALREADY RECEIVED.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">(e)	The waiver contained in Paragraph (a) and (b) above does not apply to:</font></p>
  <p style="margin-left:13.333%;text-indent:-8.333%;padding-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">(i)	Any claims for benefits under employee benefit plans in accordance with the terms of the applicable employee benefit plan, including the Executive&#x2019;s right to elect continuation coverage under the Company&#x2019;s group health, dental and/or visions plans pursuant to the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended (COBRA),</font></p>
  <p style="margin-left:13.333%;text-indent:-8.333%;padding-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">(ii)	Any right to exercise stock options or stock appreciation rights that were vested and exercisable on the Date of Termination in accordance with the terms thereof (as modified by the Employment Agreement);</font></p>
  <p style="margin-left:13.333%;text-indent:-8.333%;padding-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">(iii)	Any Claim under or based on a breach of the Company&#x2019;s obligations to pay the compensation and benefits described in Sections 5 or 7(a) or (c) of the Employment Agreement,</font></p>
  <p style="margin-left:13.333%;text-indent:-8.333%;padding-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">(iv)	Rights or Claims that may arise under the Age Discrimination in Employment Act after the date that the Executive signs this Release, and</font></p>
  <p style="margin-left:13.333%;text-indent:-8.333%;padding-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">(v)	Any right to indemnification by the Company or to coverage under directors and officers&#x2019; liability insurance to which the Executive is otherwise entitled in accordance with the Employment Agreement or the Company&#x2019;s articles of incorporation or by-laws or other agreement between the Executive and the Company.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">(f)	EMPLOYEE ACKNOWLEDGES THAT HE HAS READ AND IS VOLUNTARILY SIGNING THIS RELEASE.  EMPLOYEE ALSO ACKNOWLEDGES THAT HE IS HEREBY ADVISED TO CONSULT WITH AN ATTORNEY, HE HAS BEEN GIVEN AT LEAST </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">[21][45]</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> DAYS TO CONSIDER THIS RELEASE BEFORE THE DEADLINE FOR SIGNING IT; </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">[HE HAS RECEIVED A RECEIVED A WRITTEN DESCRIPTION OF THE JOB TITLES AND AGES ALL INDIVIDUALS SELECTED FOR THIS JOB ELIMINATION PROGRAM AND THE AGES OF ANY INDIVIDUALS IN THE SAME JOB CLASSIFICATIONS WHO ARE NOT SELECTED FOR THIS JOB ELIMINATION PROGRAM AS PROVIDED BY THE ADEA (SUCH DESCRIPTION ATTACHED AS EXHIBIT A HERETO)]</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">; AND HE UNDERSTANDS THAT HE MAY REVOKE THE RELEASE WITHIN SEVEN (7) DAYS AFTER SIGNING IT.  IF NOT REVOKED WITHIN SUCH PERIOD, THIS RELEASE WILL BECOME EFFECTIVE ON THE EIGHTH (8) DAY AFTER IT IS SIGNED BY EMPLOYEE.</font></p>
  <div class="page-node-content"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">Exhibit B &#x2013; Page </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">2</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Arial;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></div>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:36pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">BY SIGNING BELOW, BOTH THE COMPANY AND EMPLOYEE AGREE THAT THEY UNDERSTAND AND ACCEPT EACH PART OF THIS RELEASE.</font></p>
  <p style="margin-left:40%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">	</font></p>
  <p style="margin-left:40%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:24pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">	Lucy To</font></p>
  <p style="margin-left:40%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">	</font></p>
  <p style="margin-left:40%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">	(Date Signed)</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">ACCEPTED AND DATED AS OF ______________</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:36pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">SAB BIOTHERAPEUTICS, INC.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">By:  </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">						</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Name:</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Title:</font></p>
  <div class="page-node-content"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">Exhibit B &#x2013; Page </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">3</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Arial;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>3
<FILENAME>sabs-ex99_1.htm
<DESCRIPTION>EX-99.1
<TEXT>
<html>
 <head>
  <title>EX-99.1</title>
 </head>
 <body style="margin: auto!important;padding: 8px;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;">
   <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:50%;"></td>
     <td style="width:50%;"></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><img src="img1871078_0.jpg" alt="img1871078_0.jpg" style="width:134px;height:54px;">&#160;</p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Exhibit 99.1</font></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:18pt;font-family:'IBM Plex Sans',sans-serif;min-width:fit-content;">SAB BIO Appoints Lucy To as Chief Financial Officer</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:18pt;font-family:'IBM Plex Sans',sans-serif;min-width:fit-content;">   </font></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#212529;white-space:pre-wrap;font-size:11pt;font-family:'IBM Plex Sans',sans-serif;min-width:fit-content;">July 31, 2024</font></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#212529;white-space:pre-wrap;font-size:11pt;font-family:'IBM Plex Sans',sans-serif;min-width:fit-content;">MIAMI, FL July 31, 2024 &#x2013; SAB Biotherapeutics, Inc. (Nasdaq: </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'IBM Plex Sans',sans-serif;min-width:fit-content;">SABS</font><font style="color:#212529;white-space:pre-wrap;font-size:11pt;font-family:'IBM Plex Sans',sans-serif;min-width:fit-content;">), (&#x201c;SAB&#x201d; or the &#x201c;Company&#x201d;), a clinical-stage biopharmaceutical company with a novel immunotherapy platform that is developing human anti-thymocyte immunoglobulin (hIgG) for delaying the onset or progression of type 1 diabetes (T1D), today announced that Lucy To has been named Chief Financial Officer effective August 12, 2024. Ms. To brings over 18 years of investment banking and strategic operational expertise to SAB and will lead corporate finance, corporate strategy and approach to broader strategic business relationships at the company.</font></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#212529;white-space:pre-wrap;font-size:11pt;font-family:'IBM Plex Sans',sans-serif;min-width:fit-content;">&#x201c;Lucy&#x2019;s proven track record and experience will prove invaluable to SAB as we continue to deliver on our upcoming milestones for SAB-142,&#x201d; notes Samuel J. Reich, Chairman and CEO of SAB. &#x201c;I&#x2019;m thrilled to welcome her to our team and look forward to her impact on the organization as we deliver value to our shareholders and transform the landscape of T1D.&#x201d;</font><font style="color:#212529;white-space:pre-wrap;font-size:11pt;font-family:'IBM Plex Sans',sans-serif;min-width:fit-content;">  </font></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#212529;white-space:pre-wrap;font-size:11pt;font-family:'IBM Plex Sans',sans-serif;min-width:fit-content;">&#34;I am incredibly excited to join the SAB team during this transformational time for the company where we expect top-line Phase 1 data for our lead candidate, SAB-142, in T1D by the end of 2024&#34; said Ms. To. &#34;The opportunity to work at a company that has the potential to generate best-in-disease data, transform the T1D landscape significantly, and alter the course of this complex and life-threatening autoimmune disease is highly attractive. I look forward to being a part of this stellar team and contributing in the effort to make SAB's therapies a reality for patients.&#34;</font></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#212529;white-space:pre-wrap;font-size:11pt;font-family:'IBM Plex Sans',sans-serif;min-width:fit-content;">Prior to joining SAB, she was a Managing Director in the Healthcare Investment Banking Group at Wells Fargo where she advised biopharmaceutical companies on financing and strategic transactions. Her career experience includes additional investment banking and operational experience at Deutsche Bank, Intercept Pharmaceuticals, Citigroup, and Cowen. Her transaction experience includes M&amp;A, IPOs and other equity and debt financings in the healthcare sector with an aggregate transaction value in excess of $50 billion.</font><font style="color:#212529;white-space:pre-wrap;font-size:11pt;font-family:'IBM Plex Sans',sans-serif;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#212529;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'IBM Plex Sans',sans-serif;min-width:fit-content;">About SAB BIO</font></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#212529;white-space:pre-wrap;font-size:11pt;font-family:'IBM Plex Sans',sans-serif;min-width:fit-content;">SAB BIO (SAB) is a clinical-stage biopharmaceutical company focused on developing human, multi- targeted, high-potency immunoglobulins (IgGs), without the need for human donors or convalescent plasma, to treat and prevent immune and autoimmune disorders. The Company&#x2019;s lead asset, SAB-142, targets T1D with a disease-modifying therapeutic approach that aims to change the treatment paradigm by delaying onset and potentially preventing disease progression. Using advanced genetic engineering and antibody science to develop Transchromosomic (Tc) Bovine&#153;, the only transgenic animal with a human artificial chromosome, SAB&#x2019;s DiversitAb&#153; drug development production system is able to generate a diverse repertoire of specifically targeted, high-potency, human IgGs that can address a wide range of serious unmet needs in human diseases without the need for convalescent plasma or human donors. For more information on SAB, visit: https://www.SAB.bio/ and follow SAB on Twitter and LinkedIn.</font></p>
  <div class="page-node-content"><div style="flex-direction:column;display:flex;min-height:1in;justify-content:flex-end;"></div></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#212529;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'IBM Plex Sans',sans-serif;min-width:fit-content;">Forward-Looking Statements</font></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#212529;white-space:pre-wrap;font-size:11pt;font-family:'IBM Plex Sans',sans-serif;min-width:fit-content;">Certain statements made in this current report that are not historical facts are forward-looking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Forward-looking statements generally are accompanied by words such as &#x201c;believe,&#x201d; &#x201c;may,&#x201d; &#x201c;will,&#x201d; &#x201c;to be,&#x201d; &#x201c;estimate,&#x201d; &#x201c;continue,&#x201d; &#x201c;anticipate,&#x201d; &#x201c;intend,&#x201d; &#x201c;expect,&#x201d; &#x201c;should,&#x201d; &#x201c;would,&#x201d; &#x201c;plan,&#x201d; &#x201c;predict,&#x201d; &#x201c;potential,&#x201d; &#x201c;seem,&#x201d; &#x201c;seek,&#x201d; &#x201c;future,&#x201d; &#x201c;outlook,&#x201d; and similar expressions that predict or indicate future events or trends or that are not statements of historical matters. These forward-looking statements include, but are not limited to, statements regarding future events, including the development and efficacy of our T1D program and other discovery programs.</font></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#212529;white-space:pre-wrap;font-size:11pt;font-family:'IBM Plex Sans',sans-serif;min-width:fit-content;">These statements are based on the current expectations of SAB and are not predictions of actual performance, and are not intended to serve as, and must not be relied on, by any investor as a guarantee, prediction, definitive statement, or an assurance, of fact or probability. These statements are only current predictions or expectations, and are subject to known and unknown risks, uncertainties and other factors which may be beyond our control. Actual events and circumstances are difficult or impossible to predict, and these risks and uncertainties may cause our or our industry&#x2019;s results, performance, or achievements to be materially different from those anticipated by these forward-looking statements. A further description of risks and uncertainties can be found in the sections captioned &#x201c;Risk Factors&#x201d; in our most recent annual report on Form 10-K, subsequent quarterly reports on Form 10-Q, as may be amended or supplemented from time to time, and other filings with or submissions to, the U.S. Securities and Exchange Commission, which are available at https://www.sec.gov/. Except as otherwise required by law, SAB disclaims any intention or obligation to update or revise any forward-looking statements, which speak only as of the date they were made, whether as a result of new information, future events, or circumstances or otherwise.</font></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#212529;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'IBM Plex Sans',sans-serif;min-width:fit-content;">CONTACTS</font></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#212529;white-space:pre-wrap;font-size:11pt;font-family:'IBM Plex Sans',sans-serif;min-width:fit-content;">Media Relations:<br>khollon@sab.bio</font></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#212529;white-space:pre-wrap;font-size:11pt;font-family:'IBM Plex Sans',sans-serif;min-width:fit-content;">Investor Relations:<br></font><font style="color:#212529;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'IBM Plex Sans',sans-serif;min-width:fit-content;">Kevin Gardner</font><font style="color:#212529;white-space:pre-wrap;font-size:11pt;font-family:'IBM Plex Sans',sans-serif;min-width:fit-content;"><br>LifeSci Advisors<br></font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'IBM Plex Sans',sans-serif;min-width:fit-content;">kgardner@lifesciadvisors.com</font></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#212529;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'IBM Plex Sans',sans-serif;min-width:fit-content;">Chris Calabrese</font><font style="color:#212529;white-space:pre-wrap;font-size:11pt;font-family:'IBM Plex Sans',sans-serif;min-width:fit-content;"><br>LifeSci Advisors<br></font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'IBM Plex Sans',sans-serif;min-width:fit-content;">ccalabrese@lifesciadvisors.com</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'IBM Plex Sans',sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <div class="page-node-content"><div style="flex-direction:column;display:flex;min-height:1in;justify-content:flex-end;"></div></div>
  <hr style="page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>img1871078_0.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img1871078_0.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" !6 -8# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#]4Z*** "B
MBN(T[XR>$]<\>:GX,TK5H=2\0Z9:-=WEO;?.ENH8+M=QP'R?N]1WQ5QA*=W%
M7L*Z6YV]?/7PY_:BNO''QHN/!TFBPVVG/+<0VURLA,H,08Y<=,$(>G3(ZUXW
M^RO^UYX^^/7[1']D:U+96'A];"ZF33+"#"[E*A2SL2S$9]0/:LW]GS_DZFW_
M .OW4/\ T7-7T4<L^KJM#$).2C=>6_\ D?#9[F>(PV+P%/#SM&I4M+;57BK?
MBS[[HKR#1OVF/#NM?%J;P)%9WB7*S26L=\P7RI)D!W+C.0/E.#[5\Y?\-@>/
MO#?[8FH?#R:2QU7PQ=>(4TV*&Y@VRVL;E1E)%QG&>C UYU'+<16<DE9J/-KV
M/J</F&%Q:<L//F2;B[=&NA]V45QFE_&#PEJWQ$U;P-%J\47BK30CRZ;/\DCH
MR!PT>?OC##..1WKLZ\Z4)0LI*U]3T+I[!115+6-:L/#^FSZAJE[;Z=80+OEN
MKJ58XXQZEF( J4FW9#+M%?.?BC]O[X,>&;AX$\0W&M2H<'^RK*25?P<@*?SK
ME&_X*;?"<2;1IGBEA_>%A#C_ -'UZ4<LQLU=4I?<9>U@NI];T5\U^&_^"A7P
M8\07"0S:U?:([' .IV#H@^K)N4?B:^@?#OB;2/%^DPZIH>IVNK:=,,QW5G,L
ML;?BIZ^U<U;"U\/_ !H./JBXRC+9FG117E_QJ_:0\$? $:4/%M[<0RZD9/L\
M-I;F9R$QN8@=!\P&3U-94Z4ZTU"FKM]$-M15V>H45\O?\/'?@S_S_:S_ ."M
M_P#&O;/A)\8/#/QN\)+XC\*W<EUIWG/;N)HC')'(O564].""/8BNBM@L3AX\
M]6FTO-$J<9:)G:T45\Z>+/V]OA/X*\4:KH&IWFK)J.F7+VMPL>G.ZB13@X/<
M9[UE1P];$-JC%R:[#E)1W9]%T5\O?\/'?@S_ ,_VL_\ @K?_ !H_X>._!G_G
M^UG_ ,%;_P"-=?\ 9F-_Y\R^YD^TAW/J&BOF?3_^"B7P6OKE(7UC4K,,<>;<
M:9*$'U*@XKZ#\,>*=(\::'::SH6HV^JZ5=+OAN[5PZ./J.X/!'45S5L+7PZ3
MK0<;]T5&49;,U:***Y2@HHKP_P#;"^.1^!/P;O\ 4K*41^(-2;[!I?JLK [I
M?^ *"WUV^M;T*,\15C2ANW8F4E%79=USXW:-XPF^*WA+09GGO?"VB/)>7T+X
M1)Y(YOW2D?Q)Y>21T)QU!KXH_P""8[%_BMXO9B69M 8EF.229DR36]^PAX7U
M^Q^''QH\1:GIU[!IFJ:&1;:A=(56Z=8[DR%6/WL;AENG/6L#_@F+_P E4\7?
M]B^?_1J5]K]7IX3#8RC3=TE'7SMK^)Q<SG*$GYF)_P $Y?\ DYK_ +A=Y_-:
M];_9\_Y.IM_^OW4/_1<U>2?\$Y?^3FO^X7>?S6O6_P!GS_DZFW_Z_=0_]%S5
MUYC_ !\1_P!>U_[<?GO$/^^99_U]_6 GP_\ ^3PE_P"Q@O/_ &K7D'BG_E(L
M/^QRM_\ T)*]?^'_ /R>$O\ V,%Y_P"U:\@\4_\ *18?]CE;_P#H24Z'\6?_
M %Z_47!_^[XC_K]+\D+^U7<36?[=DTT$KP3)J6E%9(V*LOR0]"*_1FT^-6A2
M_&C4/AI<,;37X;"'4;7S&&V[C;=O"?[2;<D>ASV./SB_:TX_;FNB>!_:.E?^
M@0UU_P#P4 M?%W@/]I+2OB#I=G>V-I;V=H;+64C)A%Q&SDH6' /(!4XR#7-6
MPD,;##49.S=/3U]VQ^AQFX<S\S]+Z_-#_@IM\1-8O_BCI7@S[1)%H5AI\=[]
MF5B$FFD9QO8=RH4 9Z9/K7WO\$_BC9?&7X7Z!XML@$%_;@SP@Y\F=?EEC_!@
M1],5XO\ MD_L@2?M"QV&O>'[V#3_ !7IT)MPEUD0WD.2P1F )5@2<-@CG!]1
M\_E-2G@L<OK.EKKT9T54YT_=/@']G+]FG6OVD=8U6QTG6-.T==-B26:2]+,[
M!B0-B+R>G)X X]:^AC_P2O\ $'E\>/M-W^GV"3'_ *%7S]KO[)_QI\"WS,?!
M&MM)$>+K1P;D?4-"2?T%931_&K0#M/\ PG^GE>P:^CQ^M?=UI5Z\^;"XF*CV
MLG^-S@CRQ5I1.Z^-G[#'Q"^#.FVVI((?%NGS3" MHL,LDT3$$C=%MSM.#\PR
M >O45U'[#>H_$7X6_&S2=.E\/Z_:^&-=D-IJ$-Q83) K%3Y<QRN%*L -WH2*
M\D@_:!^-'@]EW>-/%=A@X"WTTI!]L2 YKZ%_9T_X*'^+(?%VEZ#\17M]:T>^
MG2V&JI"L-Q:LQ"JS;0%=,D9X![Y/2L<5#'2PDZ<XQJ73VT?W6M=>I47#G35T
M?I S"-2S$*JC))X %?C-^UI\9&^-OQLUK6()C)HMFW]GZ8N>/(C)&\?[[;G_
M !'I7Z&_MW?&C_A4_P $;VSL;CRM=\1$Z;:;3ADC(_?2#Z)Q]7%?D]X>TN#6
M-=TW3[B]ATRVN;B.&6\N#B.!&8!I&/HHR?PKR>&\)RQEBY^B_5_I]YKB9ZJ"
M.GUSX1Z_X?\ A;X<\?7<&W0]=NI[6V;!R#'C#'V<B3'_ %S-?0G_  3C^,W_
M  @_Q5N/!M_/LTGQ.H6 ,?E2\0$I_P!]KN7W(6O?_C'XX^ _C3]G&Z^'&E^/
M-"B%A81KI.9"-D\"YB.<=6(()_VV]:_,_2]3N]%U*SU&RF:VOK29+B"9#RDB
ML&5A]"!7LT9O-L+5I5H..KM=6TWB_E^ABU[&2:9^^M?B/^T=_P E^^(?_8<N
MO_0S7Z\_ ?XJ6OQG^%/A_P 66Q42WEN!=1*?]5<+\LJ?@P./8BOR&_:._P"2
M_?$/_L.77_H9KP.&Z<J6)K0FK-*WXF^)=XIH]M_9K_85@_:!^&$/BZ3QG+H;
M27<UM]D731.!Y;8W;C*O7TQ7J?\ PZHM?^BES_\ @E7_ ./U\2>&[/QS-I:M
MH$/B)].WL =,6X,.[^+&SC/K6I_9WQ4_Y]O&7_?-W7T%:AC95).&*45?1<JT
M.>,H6UB7?VB?@P?@'\4+WP@=8CUQ88(KA;M8O*)609"LFYMI'U/&#7V3_P $
ML=8U&X\*^.M+E:1]*M;VWF@#$[4E=&\P#ZA4)K\_O$&DZWIEWOUVRU"TNI_F
MWZC%(CR>IRXR:^_?^":7QGT*31;WX:/IL.FZY&TFI17D9)_M%20'W9Z.@VC
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M2^-?B;K$WA+09O\ 2+G4M:DW7URO7(5S\@/9GQ[*:^SJ02H<E9*C1?3[4O\
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M?^W0O[/_ ,,8?")\(-K1CNYKG[4+X0Y\QL[=NP]/K7J/_#U1?^B=/_X-1_\
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MY)[GA),GLVU_0FO*_$7PY^-?[$?B9M9TZXN+?2V<#^UM-S-I]TO99D(P#[.
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7 %%%% !1110 4444 %%%% !1110!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>5
<FILENAME>sabs-20240726.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- DFIN New ActiveDisclosure (SM) XBRL Schema Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2024-07-30T16:49:45.8806+00:00 -->
<!-- Copyright (c) 2024 Donnelly Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema targetNamespace="http://www.sab.bio/20240726" attributeFormDefault="unqualified" elementFormDefault="qualified" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:sabs="http://www.sab.bio/20240726" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink">
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance"/>
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase"/>
  <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt"/>
  <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd" namespace="http://xbrl.sec.gov/dei/2024"/>
  <xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd" namespace="http://fasb.org/us-gaap/2024"/>
  <xsd:import schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" namespace="http://www.xbrl.org/dtr/type/2022-03-31"/>
  <xsd:annotation>
    <xsd:appinfo>
      <link:roleType roleURI="http://www.sab.bio/20240726/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document And Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:linkbase id="lnk">
        <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" xlink:type="simple"/>
        <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" xlink:type="simple"/>
        <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" xlink:type="simple"/>
        <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" xlink:type="simple"/>
        <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" xlink:type="simple"/>
        <link:arcroleRef arcroleURI="http://www.esma.europa.eu/xbrl/esef/arcrole/wider-narrower" xlink:href="http://www.xbrl.org/lrr/arcrole/esma-arcrole-2018-11-21.xsd#wider-narrower" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.sab.bio/20240726/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="sabs-20240726.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple"/>
        <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:title="labelLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationTable" xlink:label="dei_DocumentInformationTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleCommonStockMember" xlink:label="us-gaap_ConvertibleCommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="sabs-20240726.xsd#sabs_WarrantsEachExercisableForOneShareOfCommonStockAtExercisePriceOf11.50PerShareMember" xlink:label="sabs_WarrantsEachExercisableForOneShareOfCommonStockAtExercisePriceOf11.50PerShareMember"/>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CoverAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AmendmentFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CityAreaCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentType_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line Two</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityExTransitionPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Ex Transition Period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityFileNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation, State or Country Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityRegistrantName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_LocalPhoneNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Pre-commencement Issuer Tender Offer</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Pre-commencement Tender Offer</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_Security12bTitle_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Title of 12(b) Security</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_SecurityExchangeName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_SolicitingMaterial_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_TradingSymbol_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_WrittenCommunications_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentInformationTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Information [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentInformationLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Information [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConvertibleCommonStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Convertible Common Stock [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of Stock [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfStockDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of Stock [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sabs_WarrantsEachExercisableForOneShareOfCommonStockAtExercisePriceOf11.50PerShareMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Warrants Each Exercisable for Common Stock [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sabs_WarrantsEachExercisableForOneShareOfCommonStockAtExercisePriceOf11.50PerShareMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Warrants Each Exercisable for Common Stock [Member]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentInformationTable" xlink:to="dei_DocumentInformationTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentInformationLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleCommonStockMember" xlink:to="us-gaap_ConvertibleCommonStockMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_ClassOfStockDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sabs_WarrantsEachExercisableForOneShareOfCommonStockAtExercisePriceOf11.50PerShareMember" xlink:to="sabs_WarrantsEachExercisableForOneShareOfCommonStockAtExercisePriceOf11.50PerShareMember_lbl"/>
        </link:labelLink>
        <link:presentationLink xlink:role="http://www.sab.bio/20240726/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationTable" xlink:label="dei_DocumentInformationTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleCommonStockMember" xlink:label="us-gaap_ConvertibleCommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="sabs-20240726.xsd#sabs_WarrantsEachExercisableForOneShareOfCommonStockAtExercisePriceOf11.50PerShareMember" xlink:label="sabs_WarrantsEachExercisableForOneShareOfCommonStockAtExercisePriceOf11.50PerShareMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentInformationTable" order="9000.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationTable" xlink:to="dei_DocumentInformationLineItems" order="9100.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_ConvertibleCommonStockMember" order="11501.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="11000.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="9050.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="sabs_WarrantsEachExercisableForOneShareOfCommonStockAtExercisePriceOf11.50PerShareMember" order="12020.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" order="10010.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CityAreaCode" order="10130.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" order="10020.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" order="10000.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" order="10090.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine2" order="10091.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" order="10100.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" order="10120.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" order="10110.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" order="10040.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" order="10050.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityExTransitionPeriod" order="10200.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFileNumber" order="10060.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" order="10070.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" order="10030.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" order="10080.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_LocalPhoneNumber" order="10140.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementIssuerTenderOffer" order="10190.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementTenderOffer" order="10180.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_Security12bTitle" order="10210.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SecurityExchangeName" order="10340.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SolicitingMaterial" order="10170.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_TradingSymbol" order="10220.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_WrittenCommunications" order="10160.0" priority="2" use="optional"/>
        </link:presentationLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.sab.bio/20240726/taxonomy/role/DocumentDocumentAndEntityInformation">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationTable" xlink:label="dei_DocumentInformationTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleCommonStockMember" xlink:label="us-gaap_ConvertibleCommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain_2"/>
          <link:loc xlink:type="locator" xlink:href="sabs-20240726.xsd#sabs_WarrantsEachExercisableForOneShareOfCommonStockAtExercisePriceOf11.50PerShareMember" xlink:label="sabs_WarrantsEachExercisableForOneShareOfCommonStockAtExercisePriceOf11.50PerShareMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications"/>
          <link:definitionArc xlink:type="arc" order="9000.0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentInformationTable"/>
          <link:definitionArc xlink:type="arc" order="11501.0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_ConvertibleCommonStockMember"/>
          <link:definitionArc xlink:type="arc" order="11000.0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain"/>
          <link:definitionArc xlink:type="arc" order="11000.1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_2"/>
          <link:definitionArc xlink:type="arc" order="11000.1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="dei_DocumentInformationTable" xlink:to="us-gaap_StatementClassOfStockAxis"/>
          <link:definitionArc xlink:type="arc" order="12020.0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="sabs_WarrantsEachExercisableForOneShareOfCommonStockAtExercisePriceOf11.50PerShareMember"/>
          <link:definitionArc xlink:type="arc" order="10010.0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag"/>
          <link:definitionArc xlink:type="arc" order="10130.0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CityAreaCode"/>
          <link:definitionArc xlink:type="arc" order="10020.0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate"/>
          <link:definitionArc xlink:type="arc" order="10000.0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType"/>
          <link:definitionArc xlink:type="arc" order="10090.0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine1"/>
          <link:definitionArc xlink:type="arc" order="10091.0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine2"/>
          <link:definitionArc xlink:type="arc" order="10100.0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCityOrTown"/>
          <link:definitionArc xlink:type="arc" order="10120.0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode"/>
          <link:definitionArc xlink:type="arc" order="10110.0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince"/>
          <link:definitionArc xlink:type="arc" order="10040.0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey"/>
          <link:definitionArc xlink:type="arc" order="10050.0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany"/>
          <link:definitionArc xlink:type="arc" order="10200.0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityExTransitionPeriod"/>
          <link:definitionArc xlink:type="arc" order="10060.0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFileNumber"/>
          <link:definitionArc xlink:type="arc" order="10070.0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode"/>
          <link:definitionArc xlink:type="arc" order="10030.0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName"/>
          <link:definitionArc xlink:type="arc" order="10080.0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber"/>
          <link:definitionArc xlink:type="arc" order="10140.0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_LocalPhoneNumber"/>
          <link:definitionArc xlink:type="arc" order="10190.0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementIssuerTenderOffer"/>
          <link:definitionArc xlink:type="arc" order="10180.0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementTenderOffer"/>
          <link:definitionArc xlink:type="arc" order="10210.0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_Security12bTitle"/>
          <link:definitionArc xlink:type="arc" order="10340.0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SecurityExchangeName"/>
          <link:definitionArc xlink:type="arc" order="10170.0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SolicitingMaterial"/>
          <link:definitionArc xlink:type="arc" order="10220.0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_TradingSymbol"/>
          <link:definitionArc xlink:type="arc" order="10160.0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_WrittenCommunications"/>
        </link:definitionLink>
      </link:linkbase>
    </xsd:appinfo>
  </xsd:annotation>
  <xsd:element id="sabs_WarrantsEachExercisableForOneShareOfCommonStockAtExercisePriceOf11.50PerShareMember" name="WarrantsEachExercisableForOneShareOfCommonStockAtExercisePriceOf11.50PerShareMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2</span><table class="report" border="0" cellspacing="2" id="idm139675227981344">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document And Entity Information<br></strong></div></th>
<th class="th"><div>Jul. 26, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jul. 26,  2024<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">SAB BIOTHERAPEUTICS, INC.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001833214<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-39871<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">85-3899721<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">777 W 41st St<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 401<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Miami Beach<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">FL<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">33140<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">305<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">845-2813<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_ConvertibleCommonStockMember', window );">Convertible Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common stock, $0.0001 par value per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">SABS<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=sabs_WarrantsEachExercisableForOneShareOfCommonStockAtExercisePriceOf11.50PerShareMember', window );">Warrants Each Exercisable for Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Warrants, each exercisable for one share of Common Stock<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">SABSW<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_ConvertibleCommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_ConvertibleCommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=sabs_WarrantsEachExercisableForOneShareOfCommonStockAtExercisePriceOf11.50PerShareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=sabs_WarrantsEachExercisableForOneShareOfCommonStockAtExercisePriceOf11.50PerShareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>8
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M$4<P!L !0])T> \^>Q\ETWLJ.?]74_P$4$L#!!0    (  - _UB7BKL<P
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M[L#TA(XA+@W#<Z1#BV'7T8B+[,)&G\-8AQ#G\3\Q4EUC!4NJ#AX"#SE&<)W
MD!ILDU;!>"CTN*+N@U6/@24DM0H#E>QV3N7TR@ZN6>1>9!CG*(.XLH/P4:V%
M&@/8-SF0!)?DJG547>EYIM<WDUM)Z.#<@V#OX96,'<V/'W?W U!+ P04
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MUDX:?^:+X3]>?P%02P$"% ,4    "  #0/]8!T%-8H$   "Q    $
M        @ $     9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    (  - _UC_
M]==][@   "L"   1              "  :\   !D;V-0<F]P<R]C;W)E+GAM
M;%!+ 0(4 Q0    (  - _UB97)PC$ 8  )PG   3              "  <P!
M  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%     @  T#_6%%W#T(E!0
MJA8  !@              ("!#0@  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM
M;%!+ 0(4 Q0    (  - _UB?H!OPL0(  .(,   -              "  6@-
M  !X;"]S='EL97,N>&UL4$L! A0#%     @  T#_6)>*NQS     $P(   L
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64$L%!@     )  D /@(  ,D4      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>3</ContextCount>
  <ElementCount>24</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>2</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="sabs-20240726.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document And Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sab.bio/20240726/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document And Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="sabs-20240726.htm">sabs-20240726.htm</File>
    <File>sabs-20240726.xsd</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="27">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>false</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "sabs-20240726.htm": {
   "nsprefix": "sabs",
   "nsuri": "http://www.sab.bio/20240726",
   "dts": {
    "inline": {
     "local": [
      "sabs-20240726.htm"
     ]
    },
    "schema": {
     "local": [
      "sabs-20240726.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/arcrole/esma-arcrole-2018-11-21.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    }
   },
   "keyStandard": 24,
   "keyCustom": 0,
   "axisStandard": 1,
   "axisCustom": 0,
   "memberStandard": 1,
   "memberCustom": 1,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2024": 2
   },
   "contextCount": 3,
   "entityCount": 1,
   "segmentCount": 2,
   "elementCount": 31,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2024": 27
   },
   "report": {
    "R1": {
     "role": "http://www.sab.bio/20240726/taxonomy/role/DocumentDocumentAndEntityInformation",
     "longName": "100000 - Document - Document And Entity Information",
     "shortName": "Document And Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "C_e0fd659c-47e7-4b88-95e5-f49ed5ee90dc",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sabs-20240726.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_e0fd659c-47e7-4b88-95e5-f49ed5ee90dc",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sabs-20240726.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.sab.bio/20240726/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.sab.bio/20240726/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://www.sab.bio/20240726/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConvertibleCommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConvertibleCommonStockMember",
     "presentation": [
      "http://www.sab.bio/20240726/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Convertible Common Stock [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentInformationLineItems",
     "presentation": [
      "http://www.sab.bio/20240726/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentInformationTable",
     "presentation": [
      "http://www.sab.bio/20240726/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Table]",
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.sab.bio/20240726/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://www.sab.bio/20240726/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.sab.bio/20240726/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://www.sab.bio/20240726/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.sab.bio/20240726/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.sab.bio/20240726/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.sab.bio/20240726/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.sab.bio/20240726/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.sab.bio/20240726/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://www.sab.bio/20240726/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Ex Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.sab.bio/20240726/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.sab.bio/20240726/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.sab.bio/20240726/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.sab.bio/20240726/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.sab.bio/20240726/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.sab.bio/20240726/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.sab.bio/20240726/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.sab.bio/20240726/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.sab.bio/20240726/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.sab.bio/20240726/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://www.sab.bio/20240726/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.sab.bio/20240726/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "sabs_WarrantsEachExercisableForOneShareOfCommonStockAtExercisePriceOf11.50PerShareMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.sab.bio/20240726",
     "localname": "WarrantsEachExercisableForOneShareOfCommonStockAtExercisePriceOf11.50PerShareMember",
     "presentation": [
      "http://www.sab.bio/20240726/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Warrants Each Exercisable for Common Stock [Member]",
        "label": "Warrants Each Exercisable for Common Stock [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.sab.bio/20240726/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0000950170-24-088247-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000950170-24-088247-xbrl.zip
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M[W:&K+B(TRYAHRK[>SS,LP+&LMK+&4=YTR5>?KVW(UOE\67S$H_+/&%CQ):
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MM"078;WPVI6J$[20N"5!;8FGW$1#5J[T2M%=KQXO"X]/6,U>07I_D*(!]6Q
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M=N'OM(:"8G7-.5P8G_X/4$L#!!0    (  - _UB%5.+[U4H  $2" @ /
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M<("3%I%MQ\'137S&S[<\7!D(@1 6,U,1> BP+I^EXV.4@"Z.8X+V87.=Y9Y
M#0L3S"HKFRI:%XD>-B(4+IC9V5'4,-, )$V28^D)B]6^'#>*7"QB;?J"$MF,
M9'W=-UFP)4V.OU6';]-F127^'".!FP&U'42G:GE9SR)LH&I^5"$F?=I0UF_N
M+?/.6.9K[U6R7N#8YC&07QT(3HB#DEGED4(8"W8+!I?!%3:;->9/)#D)-@C8
M[F IRK%T*D<Q$!)BAS05Q>033.&^C!N'K>K$JA/LQNL$/(G[F.4TNMJ<[G+^
MOK(E&2N>*F\E@^8X7Y772@WHNOEB:K@K3?MBC26\=XREER"=D2!K[\:Q5@GR
MFPHVSG;S$")$<K"# T.,1[GA*_DZPH!R1)NMJ!GXFYJ8)25Q79%3P548V7;K
MTY9:."L,P+F/QP*ZA^>GZ@_EUQ[*M7>U6.NA/-?1?%QFN<T.C#ZCL;EA)I]O
M/Z3&H\(VJ OLH^!^ID&M.G6IIIAN-].QZ:1:D=G:WVJ9'?2J2H*++-%N6.I9
M&@*\N^%I]<#7'OC: U][X.M]]RK(/D=.U0DP6\ICK,5@BV+\JNA>2ND#'988
MUH89CR6O83V -H^A5N50Q\[=QUYBIB!;KDQ;P!M@2M2X4#M4:1H3LP?!#PT/
M-X;5!L]VO%E:4K]R[-<B=M RA ^^%MO !W ?]G8>"S,)HPV<.0S2O'B$V 4E
M[\2TK E24JI_\)0I$.JO)S2A1@\R%Q3@B\6<F@3$$MG[JIGXUB_I:UX[4?/Z
M;*MK7B_KS3H[1+IV?[)TTW#4Y?^?1%E.85;J#;/<#Z;WH[KB1VUW7>TQ]K'=
M^%EI0:/IYK&QI\2+YMB;#?X%9\<>F#:Z0/RV/N+0F9.RY34O'>C$V 9=!1O0
M]-7TZYTS,%I7G9H5AV2YO359<M77\A&3KN24CFXTXI#D05J]64ZUMBEK4^YK
M<X;M_;4-_@\?U]8HIM9JAY[5[ F2+0L'=^1M]T381Z0Y5IC46M-V'%']/DR1
MHUE[E4:AJ:H.TW)<$&CR[LG&9$BE]^M0].BK&>F^3[]WYR1__S/@+S=LDKI)
MK/D&IZ4L;N_BWHAK&;;8(U7FM(.6(F/HOC@M!WN-TAF-LMUU2JYH6]IT'V5;
M=J+7Y1+O8UVU- [D1"#J[/"[[1V=CV'A3 1J=ZH6!ZLNY80$7O(&CVTJ*XLX
M'8P/;%$=_9GMS)G=;J#WK6>VH2BVZ;RZ)Q/L%^PV2U0$56O!I;YJ54'Q<O]:
M%1 8+YU'>6Z;@E?Z.7??U\R+V89O32T-6KTA'\ @)(BC-0K=B+,N5!1SY750
MY.YP\N9XZL,9F,:KYN43>%#.++49IJ^(N+"4GG++#\>Q6H2E(Z1XPJ+")/GR
M-GN4P?A5\]=J7NSZY7>UK'261G]>1!4)-KV/1BX=*2WM5+7.*X9]]\-Z&=L9
M&;O=D+T6&6LV]D?76-^X?#6C^E)'N^YRW-._=HI5C1F$39TQ]S/8?WI?.^C!
MF4;[0_ICHN+<0_H!=S"V,#CG9JP;/9@?N-%*59XJ=</8NH&%"6%I=>[?XZ0V
M0\\2;([Q],&!NT<S6;2F)"I7(T?);K-ZG%C:"LNGT?UVF;ZN)<7>Y9C2P>;V
MC*VED7UA>+H)V8/LVRE,/Q'C5(M:%0E9B;ML(#569#M(.CIQC*MZKUY==45=
M;3=>]!:;$MW?S=N3'TPB\RN<:1J]7_NH+S5)OZ<1ZK<W0T-7DBDGX%_HPONV
M,4/#P;;?CKX_&]$R/JPVRY%ZMH4B\19)3>^YMQ?;XUQ[G.L/CW/MD7??K%)_
MWFKDW<IN$]Y[=4,16%)IC11^W3?ZD)@"!3*RCV98JXC7',%KLG23CF1O>';%
M\-QN@!T<!E.B- R"K-0<=/^04/5=%UNV.+9HB\VX&E?13/N6!3+P5YV0&F?;
M>T_V5C/[@XP0:#?R1' KK 9YT0JDWTZ#, =S6,H#XPOT=SG'IAN\$,E*?%'$
M_'M<[LBL&,:N+.>W,.=)/22N:\GKZA)[&V[A%=:PMXA+SN@H9W^42(+HE$]R
M)J98-0+W?15M)?=;6/'>5_QB2G95Y!NV+!OIQ[FNH;X^V!G5#!3K+?C3[_K&
MEFA41>@H$^M4=4RPC$Y[3CU'O<C=%(1PG7NSF1:,UI#4V1H%&$"7PU\_;Q12
MA1/=[=D)-CD[1&M(O(O8%!@>G>?Q3;6UFC2R=E/CJ6K=OZVLXAAR;-3=X.&B
M]])YXUA Q;03N+HC=8ZN$<22XZVD9P^.Z;JML]T0Z=6&_C%#BZG: /=J5\#4
MB3U0YO0&38O,'JN%N#5,>]!M>:DV*2_5.+W27P6#%@0ZHP*7MLK&3<H'K[HZ
MV%N#D,2'/HB _,K 2!6S^09!&*U;$#[ 1E^Q<^IF/+D#[:3*AA6Y3E>,;<W#
M.V/H5AJ)3T <2])0F=XU%AKUB6%SJ;^%6)=P:/<MH%YMYC 'K"%=?X5"LS\G
MW^V<;,-!R9ID+;2OS@[/A]AV<!Z5<^=4T*YL0FL=9J%%BOD>J6G7-'.F22&8
MSK#WZ7@0-3AVL9XTD19W/>H65J,I.+D+.)$J+F:^AY?#0</;KZ*</7GT3;G:
MW93@$_&F-<6)5+,]^M!;X9VQPO\\925U*_PV,*5_)YP=C;$FTJOQR-Z8[XUY
M:\S?5F=WO]U6-G?;-3:[0 1]5*\.($2$#<CT4+GUU5YRIX!F%2]"5O+[NV=+
M)-K@8!5E)DWZZ)<:]T%,?3+K16"FX<X89AD'C6WJ8MA.$1-ZXZ.C+--7*4>2
MI18#M#'6-#PS-0UWNG_W#&)W>9_L[VURH_0N^-:[%EO@6?0N>)L+WI^1WOUV
M#LF9TV[6-H/#T=W6#0Z5N>F.6R;82P+NKO4CD/3RJF2Z(?- :NX;3QZ ZAD4
M?!8P8\D]=FH/MNS!ECW8LA?&]Q+&VR"-%:AYC$VB#V$P2<:2H Y%.1P*^+<%
M+HD+8PD^+0UGHSJ[18@;%^J>SE+OX'R!@[,"+':M8URG_0,)_9*.=.!9?7[D
M^\J$JRT0"=^>'_F2! @3:&U'\F/1MMN7R@V^Q4"@1=O<-F\67Q8H=:WAS9RO
MF9ZF\--R$-:;(VT'-]I!JRR84?UP+;BY.OUUE":3""<4'D!6O;F'@C=)^RZ0
M/49]Y<8P8=P9Q>Z;CC/7;1A(R)&L@%1RY3P9<D3\-Z]B2X"TE9<[2<&[RJ16
M_(9[/&&$G.;ND6-V]M4]W[^ZY_E65_=L,(F(EA7(ID3.K/ ?=*DVJ,\U]KG&
M/M>XT5QC6'5:ZO.,/[(;OBUYQAZ-U=GZSX<)ZO51NVT0%[6JSDUECA\\0=L+
ME\X67/7"Y0<4+NFM&?>VJGHXA+I@Q B&AJH:[G8Y W]G\_2+*O39=G[5T@I/
MTA@&CN+0$FY38XKGFZVB-H@'F-Z,O5*%-?Q".*"" G>'S#1ZA@@5JO5Q$>#/
MDCOK.#OU;3"0S9'!H;["58+-!AMFSLE%#KN#PLKAI*/ F'IA!+N*F"J)ZUG5
MG[=CWL1[RT",ZJY7K[PZH[S67J?P *?B=E'8<?!1OY'_)#TA>MQ&A]1T%W$;
MA$QC&LOGMR$W>O[TS@B-M3<YZ)$=R\B.)7S3 Y6V]C#?'N;;PWQ[U,6W:H47
M?Q;414[("C!6+JJ4XC$:CN]-<+ESF(B)-U#-IE510FSF8:,CY^*6C^"H%!IF
MV'XU;ZC")2,\WPI<Q49Q9]11;+S3.MF23[\S?_TE@48!$-K>W$MO;:9M6]%M
MS-VY6^/NG+C1RD#%0<GTP5N"/WR^2<>'*/=YZN"_,:CW\(9MSOX W35W>3G^
M Z/QU ,0]GG4>]K?G4&[MXB^RB+:W]MJDTA"81NU;(8Y9DK21 "?H(48)623
M,BNAGZ'.@RP:;P,!\48ME(X3$&]4;S=*/N"L&^PB[,I,(L6F51!L/JHQB%4T
MAUV;13F5:I3%+=F6VSK)WL*>IA=*.NA0[(>0FLZC!F#ZQV5(A2L&CQM'\ZB0
M'D R1&H 00<)++ZI]KW0\GV"VM6?B8@<)A5_#T?)&IRVCT^A.>\Y1R NQ<]B
M=;WCPU^0!!R?C$3P\K:)RY/,9L]*EN8[2<N=+UXB>+:TZD2B3A%FSCSI1AZ+
MG!VD@I DU2WT]"OI'V@@]<<.5.[-TQ ]J"JF6"V.!23O^-)K6";(IJRE$J7.
M0.%DZ)SB'QC.0MW\623ATPT[:EV>F\W6!_@=GYM>@W92@]HJC#;YA^+O:J>I
M+ZMDR7"JD8':U3P@O]PG89\-F\L-E[KM>3EX%-+I792UM'B_:B@(-/'G"4CL
MH+5-(<?+;/*'A\@ID33CCACI!&[6\ /XIT*9'25YR>$RN+F"]=1@1U6K7!M^
M:55]M4(64UNQI!FPB6H0,WD1F !IMDA-H[U,M#.W\Z.ZQ:J1ZE@7UUHW^LXT
M7^,-\(>M:*2Z<<>E:J+J>1>X_0RJP$;;"+: >#$P)7 [<=RMO@ ME56K00WU
M4HM&?/!NZ_.V*B[9/;?6<9F:':FSQ4"-Z9^,MG'57R;6TRB/[:[\ \S4(%)8
M_ %&5$;[$?.RE0&+<'!LT$$&+$T3V^5G,9["CVGV"8^=-&_RWF=I(7(/Q(,4
M,IE)S\LQ8IL*+MN.$E/D/6>_DI=(%056<X<(<WJH7;Y6.3_Z/(O&\.F'&W74
M+_\<)FAO2G35E' []1BP=$.?-CD:)BJ*<W$ R6G'/QM1+.*4I"7"@2<9D@CF
M"QVPYX8I&4=TMU! ( KLD\Y7/=41>HP78T^2,1NY)GPYR,?&>W +R)N6[Z+6
MN1K=RTPSC/@AJA[[<'%'PL7[6QTNQM9O.;8@S4!_XFF#7Z!E>ZD^_XE2(3UH
M\,]<3#I,;KA:@V1XS>NR7!-)D6%M<U(G#/*-/:FO\&JPQZS9&6HVQTW5#_')
M*DG7*PP:^C:$F:)CF1=@*Y4D^*M0KO2C#V"3\J+NM+BI%%%%3_)&['$N92H5
M]JI7'HP<S#/6Y363S)(./-][,QCO# YV!L,=#-Z*\W""<#GL?'>.GU?B.YEM
M?/_%\V<^FLJ@/*D TWB-F9Z6L40I%UDZ+^,I=QNV+#E;Y%#BUW; FZ3ZMLR"
M3^V>:1HF@^N99FJBU:S%3:8J&XE@C\O9LV.-/%C&G#$N);>;#<N EUC<MV9+
MQHZ#0O;W-[>J.]Y ;<?NES[*73@ UVD9A^+*&U0(YZ+(U"C49R^:+]*<,R]F
MF9^\>/&B2J>$VDC*"*6:SFG_@^.JX@)!;Y@1LM@Y"F' -0MY&2>>JK<MQ44&
MC2M\N&O*I]&&0^@2^W)JJ&O>[M/K44:"<4ZQ39CB&+_C2L=XXB8ZDV"18L]C
M*[90%TQ!NXO\1J@+M+0JP2(#01-09(CDFN9E>F^@CK6L)PO)-(&+&[]/-%K!
M:"#D*:O[)/46X.DYH;A,SU64H$ZW3S=5<XU]7<V;[Y4)P<@<%)[)/U9CG#7[
M5,N)R72A,.1(.ZH!Z:O>87/8CNOZ6H/<Q0HH,'0*#@K'X)7&%&">TQ;7N8T7
M2JQ=U(*\'-/!K/D?;N#W'24/CV_'ZV]PUNNCQ*[K/+5.-!Z/G%XN"?'-PO1E
M%7U915]6<:?G_)V]Y.XZEDM@&7:!R!JQ9LK>BZ'?%*'L14ZB+*?()\D\T?]H
M22Q#\DUA[%)XU %J+_'-IL*3(-XEO  Q,81?2NA%-8A+'U3I3%!E&TATAK"!
MC3^I&NXB[+PQDBF'>EL*"3;I,SJ)43ZP>5[.%Q8*!C,)1SV&5S",(,L8**O$
M,*LM@E\%J&CZZ\&D*F& FU-*6<%,#B."/)BV2HPD"#28MY0T691C,,D(P% F
M)#] <E%ZE5\*%IEEE\@H<0RRBL-:BZ)=;"&:3MUP' T!'6VDH]L321I6,_,:
M9J8#WE M<2_T1+A35(1HE+Q<D/,"XS4U/[3;0-S.&K2=+9R?%K(PD0+_)=B"
M]8@"'2T*)G$E.E=;U%P]S3@)Z"##KACC(Y7Q(7R[)[6",X^2A/J!Y0BS07'#
M&$_8.#JB37L;U!:!YZAUL1$84Y=@7KOJ"M98Q>HD@4F8@!.7QNBLUS<IE^FU
MW6UC;;EU&!V?+*I4^K(W8L/,DS)+HKR),!("9\.4FR[ ZV0 +\\4!8?Q8Y'I
MR!4.YE6K/U3X,*I"LU6;H,\N=B2[>+#5V<6W>@K*XS6<R(W"7$:(S%[ C-Y4
M9P'#@R 3(SRB&)M'P$MZG2#42;4)D0B))!HDZW!R" @I": %YD]=?'[=;._/
M5$?.U..M/E,.5?.FR]?K>BO$.+PM5*\JOO# U0J1:^XN:O6["D>:[B_I0?,L
M>Z)M;]"$<@4$MQG;R<+!#;!$P_>V)(/3B86N+,YE0]YE+2!SQ8J])2I&7.4X
MFF@T[WQ!2R5BT+C<XU'NO,=?\BL<%"S%C U2U\91ZM[1E^TKP4,ZAIH)D N$
M(#=A;(0"T#YWANZ3PQ-PY3Y^KOD.22&X7UF[D[)7C"\@XQ=SQ61&XP\X ?A?
MF'&%:0:,0[7,LO(26$GWC=6*]&JG(VKGR5:KG5/R\#9KQPT93(KC\(U[F",#
M%]P72DD'QS;2^;Q,!/C@]'BJ0?F-Q*JAS4.4!:1&9@K1_.BNAB7XA5.0" F*
MK5#'\,^,Q2 <=Q!3F!F,2>>P_^W@29F)3!-%V(>$L/ 7!0%[X&X.$-,A=,(Q
M^!!?.F]8']LZP[ZW2&%+39$V5Z/*\[&S#EBS.:/?&4N:K^K'8!,><A0Q2?'R
MYT=/#AJ] W?WGST"4?M7F\^B"Y\]>O*B%O']YDYR\BLJZGGYY-DF.RC6MQN:
M-S4A^]))K*R<2; M7QP\U 3MU6=G_]'!BPY-T,7PT#N,Z+RIA0:-&<!1/$F"
M9A^U[L[3^FRF1AZNV]/PG?()19&\]+RC6:0=1G?OC$OPOOMD+0N?CLW7"-7
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M$]X!%\-1H@' ,GJ#BP]'O]8^VI3$XBVVY)J.X.79S@:WYRN:N5_K,2,C)#
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M._SOB_X-4$L! A0#%     @  T#_6*Q+\[F^&0  ,K<  !$
M ( !     '-A8G,M,C R-# W,C8N:'1M4$L! A0#%     @  T#_6+<K6V%3
M#0  ,+@  !$              ( ![1D  '-A8G,M,C R-# W,C8N>'-D4$L!
M A0#%     @  T#_6(54XOO52@  1(("  \              ( !;R<  '-A
M8G,M97@Q,%\Q+FAT;5!+ 0(4 Q0    (  - _UBO19&)8 T  &8T   /
M          "  7%R  !S86)S+65X.3E?,2YH=&U02P4&      0 ! #X
&_G\

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>sabs-20240726_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:sabs="http://www.sab.bio/20240726"
  xmlns:us-gaap="http://fasb.org/us-gaap/2024"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="sabs-20240726.xsd" xlink:type="simple"/>
    <context id="C_e0fd659c-47e7-4b88-95e5-f49ed5ee90dc">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833214</identifier>
        </entity>
        <period>
            <startDate>2024-07-26</startDate>
            <endDate>2024-07-26</endDate>
        </period>
    </context>
    <context id="C_2b02be66-d2d4-400e-be24-3cd033b7a868">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833214</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">sabs:WarrantsEachExercisableForOneShareOfCommonStockAtExercisePriceOf11.50PerShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-26</startDate>
            <endDate>2024-07-26</endDate>
        </period>
    </context>
    <context id="C_61e14643-1b49-499f-ba28-dec792a3efce">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833214</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:ConvertibleCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-26</startDate>
            <endDate>2024-07-26</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey
      contextRef="C_e0fd659c-47e7-4b88-95e5-f49ed5ee90dc"
      id="F_a8e37b87-cda3-4847-9e63-87ec0c5307e9">0001833214</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="C_e0fd659c-47e7-4b88-95e5-f49ed5ee90dc"
      id="F_15654233-edf6-4004-aa4f-194c3064fe52">false</dei:AmendmentFlag>
    <dei:DocumentType
      contextRef="C_e0fd659c-47e7-4b88-95e5-f49ed5ee90dc"
      id="F_6e255dc3-d617-46ef-96c3-f3c2b68412ea">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="C_e0fd659c-47e7-4b88-95e5-f49ed5ee90dc"
      id="F_0282d1ff-295a-413b-8952-cdc853ea3e10">2024-07-26</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="C_e0fd659c-47e7-4b88-95e5-f49ed5ee90dc"
      id="F_553f0258-1e5c-4682-ab4f-1f248325a070">SAB BIOTHERAPEUTICS, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="C_e0fd659c-47e7-4b88-95e5-f49ed5ee90dc"
      id="F_d99ed54a-5b87-44d6-8465-c7a00efc2094">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="C_e0fd659c-47e7-4b88-95e5-f49ed5ee90dc"
      id="F_2ab1a74a-8dcb-4271-9bdc-79f047691453">001-39871</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="C_e0fd659c-47e7-4b88-95e5-f49ed5ee90dc"
      id="F_7e50d2ee-5e05-4da1-92fe-dc112e66a79d">85-3899721</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="C_e0fd659c-47e7-4b88-95e5-f49ed5ee90dc"
      id="F_1af538b4-751e-4925-b704-56ca8bfe0b75">777 W 41st St</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="C_e0fd659c-47e7-4b88-95e5-f49ed5ee90dc"
      id="F_066617d4-45fd-40f6-80fb-9185226ae819">Suite 401</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="C_e0fd659c-47e7-4b88-95e5-f49ed5ee90dc"
      id="F_4f4f692a-44ce-4b76-a4a2-1d920f97b097">Miami Beach</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="C_e0fd659c-47e7-4b88-95e5-f49ed5ee90dc"
      id="F_770f53d1-2ee7-4495-a005-ea5b9a4e8f19">FL</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="C_e0fd659c-47e7-4b88-95e5-f49ed5ee90dc"
      id="F_20f09587-3166-4a38-9fbd-6915c5dc7d33">33140</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="C_e0fd659c-47e7-4b88-95e5-f49ed5ee90dc"
      id="F_62b8ea17-f31a-4ca7-adb6-3eafafce6967">305</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="C_e0fd659c-47e7-4b88-95e5-f49ed5ee90dc"
      id="F_4c820b10-6f96-4e0a-9ff0-c8d8de281205">845-2813</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="C_e0fd659c-47e7-4b88-95e5-f49ed5ee90dc"
      id="F_2e72727e-559f-4e26-ad00-a781ecc59436">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="C_e0fd659c-47e7-4b88-95e5-f49ed5ee90dc"
      id="F_92034988-e9d3-491f-ac87-99ddadb10753">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="C_e0fd659c-47e7-4b88-95e5-f49ed5ee90dc"
      id="F_c109cb40-322a-452b-a087-70c7a61d05e6">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="C_e0fd659c-47e7-4b88-95e5-f49ed5ee90dc"
      id="F_67ad8dad-1b6b-44c5-826e-5f8c99ed602f">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="C_61e14643-1b49-499f-ba28-dec792a3efce"
      id="F_22b38018-1eab-4680-ad2e-14374452489b">Common stock, $0.0001 par value per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="C_61e14643-1b49-499f-ba28-dec792a3efce"
      id="F_0b9f509e-91d7-4841-a7e1-d97f1d8018ac">SABS</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="C_61e14643-1b49-499f-ba28-dec792a3efce"
      id="F_088e8f9f-2da8-489d-a21d-1d9187dfac54">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="C_2b02be66-d2d4-400e-be24-3cd033b7a868"
      id="F_90dd2a46-62c1-45fb-a881-b8a3fc4c73fc">Warrants, each exercisable for one share of Common Stock</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="C_2b02be66-d2d4-400e-be24-3cd033b7a868"
      id="F_e4c46832-a013-44c5-b70e-a53b496d4ed8">SABSW</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="C_2b02be66-d2d4-400e-be24-3cd033b7a868"
      id="F_0d4e90e7-030a-4f23-945b-b98c5193a8b3">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="C_e0fd659c-47e7-4b88-95e5-f49ed5ee90dc"
      id="F_16513a7c-8d23-4c64-b2ee-6dddb50a859c">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod
      contextRef="C_e0fd659c-47e7-4b88-95e5-f49ed5ee90dc"
      id="F_95627ca7-d3e4-414c-b836-6e9c18ce8001">false</dei:EntityExTransitionPeriod>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
